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Abstract 
Phosphoinositides are critical second messengers, and often their aberrant 
metabolism and membrane localization plays a role in the development of diseases such 
as cancer. The dynamic metabolism and localization between phosphatidylinositol-(4,5)-
bisphosphate (PI(4,5)P2) and phosphatidylinositol-(3,4,5)-trisphosphate (PI(3,4,5)P3) in 
the PI3K-AKT pathway, is in part, regulated by the protein known as phosphatase and 
tensin homolog deleted on chromosome ten (PTEN). PTEN is one of the most frequently 
mutated genes in cancer, and its location on the plasma membrane (PM) is often found 
to be polarized in cells. Despite the importantance of PTEN in health, the effects of the 
PM lipids on its localization and thus, its functional mechanism still need to be fully 
elucidated. The obstacles to fully understanding how the localization of lipids affects 
PTEN’s membrane interactions include (a) not all lipid species have probes to follow their 
location in cells, (b) lipids cannot be knocked-in and -out in cellular systems, which is 
especially true for phosphoinositides, (c) each lipid species that participates in the PTEN-
membrane interactions cannot be independently titrated in the cell, which is essential for 
defining the mechanism of PTEN-membrane interactions. Using model systems, these 
obstacles can be overcome, thus developing a more nuanced biophysical understanding 
of the system. We hypothesize that PTEN uses its multiple lipid binding domains to 
interact synergistically with a distinct ensemble of lipids in membranes, which 
efficiently localizes the protein near its substrate. PTEN localization in cellular 
systems depends on this spatiotemporal control of the phosphoinositides and 
their associated lipid partners.    
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Project 1. Ensemble Kinetics: We determined the rate constants of PTEN binding to 
multicomponent model membranes, which allowed us to elucidate the roles of individual 
lipids in this interaction. Fluorescence stopped-flow spectrophotometry was used to 
determine the rates of the interaction, and the KinTeK global fit software was used to 
interpret it. We determined the roles of phosphatidylserine, phosphatidylinositol, and 
PI(4,5)P2 in PTEN-membrane interactions and identified the interactions that drive PTEN 
to the membrane. Also, we determined whether domain formation observed for specific 
lipid compositions affected the rates of PTEN binding.   
Project 2. Single Molecule Studies: We determined how PTEN domains interact with 
model membranes of various compositions. Single-molecule TIRF microscopy was used 
to determine diffusion constants and dwell times of these constructs that were then 
compared to the wild-type (wt) protein. The outcome was that PTEN domains work 
together to interact with the membrane, resulting in a synergistic binding with the surface.  
Project 3. A novel model system to study phosphoinositide gradients: We 
developed a model system that generates gradients of phosphoinositides or the proteins 
that regulate them. Taking advantage of the lamellar flow of microfluidic platforms, we 
can generate a supported lipid bilayer with a lipid gradient or affect a homogenous lipid 
bilayer with a gradient of a dissolved chemical species above the lipid bilayer and follow 
the development of the bilayer system using TIRF microscopy. The outcome of this 
project was the development of a novel model system that can recapitulate PM 
polarization seen in cells, allowing investigation of the effects of lateral gradients in 
protein-membrane systems.   
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The proposed project will result in a nuanced biophysical understanding of the 
mechanism of PTEN interacting with complex lipid surfaces and provide greater insight 
on how peripheral proteins interact with the PM. This will provide the broader community 
with additional insight on how processes like cellular polarization and its dysregulation 
affect enzyme action and disease progression.  
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Chapter 1: Introduction - PTEN and phosphoinositides 
1.1 Phosphoinositides in the plasma membrane; more than a “solvent” for 
proteins. 
The Singer-Nicolson fluid mosaic model of biological membranes has an 
astonishing 6000 citations and has enjoyed over 45 years as the preeminent model for 
these cellular structures (Figure 1)1. This model has lipids organized as a double layer 
where the nonpolar acyl tails form a greasy core, and the polar heads interact with the 
aqueous environments within and outside the cell.  These lipids form a bilayer structure 
that proteins can associate with. Membrane-associated proteins fall into two broad 
groups, integral (transmembrane) and peripheral (surface-residing) proteins. Singer and 
Nicolson describe the membrane as fluid, where both the lipid and the proteins are mobile 
in the plane of the membrane, vertically asymmetric (the chemical components and 
composition differ from the cytosolic side to extracellular side) as well as crowded, 
Figure 1. The classic fluid mosaic model of the plasma membrane developed by Singer 
and Nicolson. This bilayer has several key features making it a stable and dynamic cellular 
structure. First, is the amphipathic nature of the main chemical constituents, the lipids. These 
biomolecules organize proteins by solvating hydrophobic regions of transmembrane 
segments as well as providing a dense, diverse chemical surface for cytosolic proteins to 
organize and interact with. The lipid bilayer is fluid, crowded and asymmetric in respect to 
the chemistry between the extracellular and cytosolic compartments of the cell. Though this 
model is the mainstay of membranes, modern investigations have discovered an even 
deeper level of organization and purpose for the lipids beyond “just acting” as a solvent for 
the proteins.     
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(proteins make up half the mass)1, 2. This microscopic model of biomembranes has 
proven to be invaluable to the field of biochemistry over the decades. However, it has 
been shown time and again that the lipids are more than just a solvent for proteins, and 
evidence of this starts with the immense diversity of these molecular species.  
The increasing sophistication and, consequently, resolution of instrumentation has 
uncovered a molecular diversity in the lipidome that rivals the proteome. Lipid MAPS, the 
internationally recognized, public, biologically relevant, lipid structural database, has 
reported 20,664 species as of 12/27/17, and a little over that amount again for 
computationally derived lipids3. From a different perspective, eukaryotic cells dedicate 
approximately 5% of their genome to lipid metabolism4, 5. Following “structure supersedes 
function” hypothesis, the natural question is why do cellular systems sacrifice so much 
energy and chemical resources to maintain this enormous lipid diversity? There are three 
major classes of membrane lipids in eukaryotes. These are the sterols/ isoprenoids, 
sphingolipids, and glycerolphospholipids. 
Figure 2 highlights the potential chemical functionality of the 
glycerolphospholipids5, 6. Chemical modifications of these molecules can occur at two 
major sites, (1) the acyl chain tails vary in both the length and saturation of the 
hydrocarbon chain and (2) the headgroup. By altering the headgroup chemistry, the cell 
derives the abundant inner leaflet phospholipids; phosphatidylethanolamine (PE), 
phosphatidylcholine (PC), phosphatidylserine (PS), cardiolipin (CL) and 
phosphatidylinositol (PI). These lipid headgroups have chemical and physical properties 
that affect lipid-lipid and lipid-protein  
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Figure 2. The chemical variability of phospholipids is due to the rich functionality of 
the molecule. The modification can occur at the head group and by varying the fatty acid 
chain length or saturation. The permutations of these chemical building blocks could generate 
tens of thousands of lipids species, naturally occurring eukaryotic membranes contain about 
1000 unique lipids. 
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interactions. For example, anionic phospholipids like PS, PI (figure 2), PG and CL have 
a net negative charge (-1) at pH 7. PE and PS have reactive amines which can participate 
in hydrogen bonding, and PC, PI, and CL headgroups are bulky, affecting lipid packing6. 
PI is of particular interest to this study because it is the precursor to a specialized class 
of signaling glycerolphospholipids known as the phosphoinositides (PIPs). 
The precursor to all PIPs is PI (Figure 2). Reversible phosphorylation can occur at 
the hydroxyls of the PI inositol headgroup at the third, fourth, and/or fifth inositol ring 
positions, yielding seven different naturally occurring PIP species. These are PI(3)P, 
PI(4)P, PI(5)P, PI(3,4)P2, PI(4,5)P2, PI(3,5)P2, PI(3,4,5)P3 (Figure 3)7. Depending on the 
membrane compartment, (endoplasmic reticulum, plasma membrane, etc.), there are a 
group of dedicated kinases and phosphatases that control the phosphorylation status of 
these lipids. These enzymes tightly control the type and concentration of the PIPs in the 
different membrane compartments, developing a “barcode” that differentiates one 
membrane from another4.  
In contrast to the headgroup diversity, the PIPs acyl chains are predominately 
stearoyl at the first (sn-1) and arachidonoyl at the second (sn-2) position7, 8. The 
arachidonoyl chain has four cis configured double bonds which disrupt tight lipid packing. 
As a result, these lipids localize in liquid disordered (fluid) regions of bilayers7. This 
preference for fluid membrane regions does not mean that PIPs cannot accumulate into 
enriched fluid domains. In this context, a lipid domain is a region in the membrane that 
exhibits a boundary with the surrounding membrane and is characterized by a distinct 
composition and physical properties. PIP clustering (formation of PIP-enriched domains), 
is driven by interactions within their headgroup region and influences interactions at the  
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Figure 3. There are seven members of the phosphoinositide family. 
They are derived from the precursor phosphatidylinositol (PI) by a series of 
dedicated kinases and phosphatases. The PIP members are PI(3)P, PI(4)P, 
PI(5)P, PI(3,4)P2, PI(4,5)P2, PI(3,5)P2, and PI(3,4,5)P3. In the plasma 
membrane PI(4,5)P2 and PI(4)P are the most common representing 2% and 
1% of the lipid pool respectively. PI(3,4,5)P3 is obtained by the 
phosphorylation of PI(4,5)P2 by the kinase PI3K. PI(3,4,5)P3 is a potent 
second messenger, yet is measured at less than 1% of the total 
phosphoinositide PM pool. 
PI(3.4.5)P3 
>1% PI(4,5)P2 
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membrane interface by providing regions of a high electrostatic negative potential that 
attract peripheral proteins to the membrane7. For example, in vitro, clusters can be seen 
with mixed domains of PI and PI(4,5)P2 in giant unilamellar PI/PI(4,5)P2/PC vesicles9. PI 
and PI(4,5)P2 cooperatively form mixed domains that potentially regulate the spatial 
organization of signaling events. Taking into account the PI cellular distribution and the 
rapid phosphorylation of PI to form PIPs, it is enticing to think that these mixtures may be 
enriched with peripheral proteins that have dual specificity for anionic lipids and PIPs7. 
This would form a signaling platform that is dynamic due to the fluidity of the lipid 
constituents but also solves the scarcity paradox of PIPs by enriching them in domains. 
The scarcity paradox of PIPs recognizes that these lipids are extremely rare but 
incredibly potent for protein function. The percent composition of the precursor, PI, in the 
plasma membrane varies from 10-20%, depending on the cell type and tissue, but PIPs 
in total make up less than 1% of the total cellular lipid pool.  PI(4,5)P2 and PI(4)P are the 
most abundant PIPs, enriched in the PM and Golgi respectively  (~0.2-1%)7. This means 
there is approximately 5000-20,000 PI(4,5)P2/μm2 in the plasma membrane’s cytosolic 
leaflet7. The other PIPs exist at approximately 0.2-0.3% for PI(3)P, and 0.02-0.05% for 
PI(3,4,5)P3, even at activated levels (Figure 4)7, 10. The tight spatiotemporal control is not 
surprising considering the functions that the PIPs influence, such as membrane 
trafficking, cytoskeleton dynamics, endocytic/exocytic machinery and chemotaxis7, 11. 
Interestingly, despite these low concentrations of PIPs, the number of proteins with 
domains specific for the individual PIP species is large in magnitude and vast in type. This 
dichotomy between low PIP levels, and high abundance of PIP-binding proteins is at the 
center of the “scarcity paradox.” Table 1 lists just a few of the most well-known domains 
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Figure 4. The rarity of the phosphoinositides belies their importance.  The most 
abundant phosphoinositide is PI(4,5)P2 at 2%, of the lipid pool, and PI(3,4,5)P3 is about 1% 
of the PI(4,5)P2 population. Yet, there are many types of proteins that interact specifically 
and nonspecifically with the phosphoinositides making them a high demand substrate. If 
the lipids are randomly distributed as in the figure above and the protein footprint covers 
100 to 150 lipids it would need to sort through 5000 lipids to find one PI(3,4,5)P3.  
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that have interactions with these lipids12. This thesis is concerned with PI(4,5)P2 and 
PI(3,4,5)P3, and one of the proteins that is  critical in regulating them, which is PTEN 
(phosphatase and tensin homolog deleted on chromosome 10). 
 
 
  
 
DOMAIN 
HUMAN PROTEINS CONTAINING THE 
MOTIF 
PH 259 
C2 118 
C1 53 
PX 30 
FYVE 28 
GRAM 58 
BAR 10 
ENTH/ANTH 9 
Table 1. The number of proteins containing these domains was gathered by using the SMART 
database. The number here is comparable to those in Lemmon et al. 7,8. These domains were identified 
by architecture analysis in the Genomic mode. Genomic SMART only shows the proteomes of 
completely sequenced genomes and has a greatly reduced redundancy as seen with Normal SMART. 
ANTH, AP180 N-terminal homology; BAR, Bin, amphiphysin and Rvs; C1, conserved region-1; C2, 
conserved region-2; ENTH, epsin N- terminal homology; FYVE, Fab1, YOTB, Vac1, EEA1; GRAM, 
glucosyltransferases, Rab-like GTPase activators and myotubularins; PH, pleckstrin homology; PX, 
Phox homology.  
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1.2 PIPs, PTEN, and Disease 
In advanced cancers, there is commonly a loss of heterozygosity (LOH) on the 
long arm of chromosome 1013, 14. This has been reported at a frequency of 70% with 
glioblastomas, 60% advanced prostate cancers and 50% primary invasive breast 
cancers. PTEN is located at 10q23 which is a site that frequently experiences this LOH13-
15. The types of mutations and deletions identified in this gene in multiple tumor types 
include insertions, missense mutations, nonsense, and frameshifts. Parsons et al. 
reported in a seminal paper that PTEN mutations occurred at a rate of 63% (5/8) in 
glioblastomas, 100% (4/4) prostate cancers and 10% (2/20) in breast cancers propelling 
the protein to the front of cancer research 14-16.  PTEN mutations are also found in 
endometrial tumors (34%-45%)17-19, bladder tumors (14%)20, kidney15, and glioblastoma 
multiform (GBM) (20%-24%)19, 21, 22 (Table 2: COSMIC database)13, 17, 23. 
  Not surprisingly PTEN germline mutations are associated with chronic tumor 
growth and are associated with diseases such as Cowden disease, Lhermitte Duclos 
disease, and Bannayan-Riley-Ruvalcaba syndrome7, 11, 13, 15, 24-27. Today, germline 
mutations of PTEN have an umbrella term, PTEN Hamartoma Tumor Syndrome (PHTS).  
It encompasses the range of symptoms identified with PTEN mutation carriers and 
provides broader diagnostic criteria27. Research in mouse models and in vitro further 
established the function of PTEN, and how the mutated protein leads to the progression 
of tumorgenesis28.  
 PTEN was identified as a dual specificity phosphatase (DSP) when the iconic H-
C-X-A-G-X-X-R-(S/T)-G sequence of that family was discovered14, 29. The catalytic activity 
of PTEN is unique among the DSP. Its target is the 3-phosphate on the lipid PI(3,4,5)P3   
14 
 
 
  
TISSUE 
%POINT 
MUTATIONS 
TOTAL 
SAMPLES 
BILIARY TRACT 2.81 533 
BREAST 3.72 5146 
CENTRAL NERVOUS SYSTEM 12.4 6418 
CERVIX 3.85 1092 
ENDOMETRIUM 37.88 3332 
EYE 3.22 311 
GENITAL TRACT 2.58 194 
HAEMATOPOETIC AND LYMPHOID 2.46 9807 
KIDNEY 3.05 2493 
LARGE INTESTINE 5.06 6169 
LIVER 1.91 2570 
LUNG 2.46 6293 
OESOPHAGUS 1.63 1592 
OVARY 3.25 2212 
PANCREAS 1.16 2503 
PROSTATE 6.39 2661 
SALIVARY GLAND 4.46 448 
SKIN 8.12 2637 
SMALL INTESTINE 3.45 58 
STOMACH 3.25 2029 
THYROID 2.23 1747 
URINARY TRACT 2.07 1016 
VULVA 8.33 144 
Table 2.0 COSMIC database results of PTEN point mutations for different tumor tissues. Date 
accessed 1/19/2018 http://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=PTEN. 
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as reported by Dixon et. al30. While PTEN has some protein phosphatase activity that it 
exerts in the nucleus31, it potently targets PI(3,4,5)P3 in the PM. When comparing the km 
between inorganic Ins(1,3,4,5)P4 to p-nitrophenyl phosphate, there is 250-fold difference 
favoring the inositol derivative. Also, when comparing the specificity for the 
phosphoinositide targets, PTEN overwhelmingly favors PI(3,4,5)P3. PTEN turns over this 
lipid 80% faster than either PI(3)P or PI(3,4)P230. PTEN’s phosphatase activity makes it 
an antagonist to the PI3K-Akt cell survival pathway (Figure 5)22.  
PTEN’s regulatory role in the PI3K-Akt pathway puts it at the center of cancer 
development and progression. At the beginning of the PI3K-Akt signaling pathway are the 
enzymes PI3K and AKT. The kinase PI3K phosphorylates PI(4,5)P2 to produce 
PI(3,4,5)P3. PI(3,4,5)P3 influences cell survival and proliferation by inducing 
phosphorylation and activation of Akt kinase11, 32, which signals the cell for growth, 
proliferation, extracellular matrix interactions, and motility. Non-functioning PTEN leads 
to constitutively activated Akt11, 30, 32. Activated Akt is a potent cell survival that leads to 
tumor progression33.  
In mice, PTEN null mutations result in death by day 9.5 of development28. In 
fibroblasts, derived from these mice, there was a dramatic loss of sensitivity to apoptotic 
stimuli (UV irradiation, heat shock, osmotic stress, tumor necrosis factor α (TNF-α)) where 
large populations of cells survived these stressors. While low levels or inactive PTEN 
inhibits apoptotic pathways, high levels of PTEN can lead to premature cell death. PTEN 
belongs to a class of ‘gatekeeper” tumor suppressor genes which is shared with the likes 
of p53, Rb and APC. These genes are vital in regulating normal cell growth , and any 
mutation directly contributes to neoplastic cellular growth13, 32.  
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Figure 5. PI3K-Akt signaling pathway and PTEN’s regulatory role in humans. Class 1a 
PI3K is responsible for phosphorylating PI(4,5)P2 to produce PI(3,4,5)P3. The kinases AKT 
and PDK1 can than co-localize to the membrane by binding directly to PI(3,4,5)P3. PDK1 
phosphorylates and activates AKT. After AKT is further phosphorylated by mTOR, it can 
activate and deactivate many different downstream protein targets which result in cell growth, 
proliferation, cell cycle progression, chemotaxis, and tumorigenesis. PTEN downregulates 
this pathway by dephosphorylating PI(3,4,5)P3 back to PI(4,5)P2.   Figure adapted from 
Carnero, A. et al33.  
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1.3 The Structure of PTEN 
It was first hypothesized that PTEN could drive itself to the membrane based on 
its crystal structure (Figure 6) 34. The signature sequence of PTEN is (H-C-K-A-G-K-G-
R) 123-130aa, which is also known as the P-loop and is colored cyan in Figure 6 11, 34. 
PTEN has the highly conserved residues (green) required for protein phosphatase activity 
but also has two unique Lys residues (red)11, 34. PTEN’s phosphatase domain is both 
wider and deeper than exemplary phosphotyrosine domains. It is thought that the 
machinery was originally for protein phosphatase activity but has since diverged to be 
preferential for PI(3,4,5)P3 11, 34. This motif is also conserved in yeast homologs of 
PTEN34.   
Overall there is weak predictive information linking the type of mutation to tumor 
type, but usually, there are mutations found in the phosphatase domain21, 26, 27, 35. This 
domain (PD, purple in Figure 6) of PTEN has a central five stranded β-sheet that packs 
with two α helices on one side and four on the other. In the catalytic domain, residues 
C124 (yellow in Figure 6) and R130 (orange in Figure 6) are critical for function. The 
specificity of the pocket is from the interactions of K128, H93, and K125 (green, blue, and 
purple respectively in Figure 6).  Mutation studies have shown that the K128M and H93A 
mutants reduce phosphatase activity towards PI(3,4,5)P3 specifically while retaining 
activity towards proteins and the other 3-phosphorylated PIP derivatives. These results 
suggest that K128 and H93 interact with the D5 phosphate of PI(3,4,5)P319. The 
importance of this interaction is shown by the conservation of H93 in PTEN orthologs. In 
contrast to this, the  
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Figure 6. The structure of PTEN. (A) The partial crystal structure of PTEN lacks the N-terminal PBD 
domain, internal loops, and the C-terminal tail. What is represented in the crystal structure is the PD domain 
in purple with the catalytic P-loop highlighted in cyan. The explicit amino acids are important for selectivity 
and catalytic function. The C2 domain is represented in grey. It lacks the CBR3 loop which is implicated in 
membrane binding. (B) Is the domain map of PTEN where the size of the domains are to scale relative to 
the number of amino acids within each.  
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K125M mutation reduces the lipid phosphatase activity to all D3 containing 
phosphoinositides, indicating loss of PTEN function. In vitro experiments showed a 75%  
reduction in turnover and cells expressing any of these mutations proliferated 
extensively19, 34 
PTEN also contains a C2 domain (grey in Figure 6) 8, 34. C2 domains are the 
second most abundant lipid binding domains following the PH domains (Table 1)7. The 
C2 domain aids in the targeting of PTEN to the bilayer-water interface by Ca2+-
independent binding to anionic lipids36. The C2 domain structure is mostly beta sheet, 
and it stabilizes the PD domain through several interdomain contacts. In cancer, this 
highly conserved interface region between the two domains contains many mutations, 
leading to structural instability of the protein34.  The C2 domain has a conserved eight-
stranded antiparallel β-sandwich structure connected with surface loops and two short α-
helices between the strands7, 34. The PTEN C2 domain primary amino acid sequence is 
not well conserved when compared to other C2 domains, but shares its sequence with 
Auxilin and Tensin34. It was only identified as a C2 domain after the crystal structure was 
elucidated34. 
Unlike the C2 domains that bind to anionic lipids in a Ca2+-dependent manner, 
PTEN’s C2 domain has only one of the three CBR loops, CBR3; which is not solved for 
in the crystal structure. It is hypothesized that the +5 charged loop, with two hydrophobic 
amino acids at its end is a significant player in the interaction with anionic phospholipids34. 
Mutation of the putative membrane-binding residues results in inhibition of PTEN’s 
biological activity19. C2 domains have been shown to bind PIP2 along with the other 
anionic lipids7. PTEN’s C2 domain is similar to that of PLCδ1, PKCδ, and cPLA211, 34. The 
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C2 domain is followed by two PEST motifs and a PDZ consensus sequence; which not 
included in the crystal structure 11.    
Physiologically, C-terminal truncation results in rapid degradation and specifically 
the loss of the PEST sequence results in lower PTEN levels. Nevertheless, PTEN with 
deletion of this C-terminal sequence is still functional in cells. Mutations in this region are 
found in Cowden syndrome and can occur at Thr321, Arg323, and Arg335. As for the 
PDZ site, it is tempting to postulate this domain aids in PTEN targeting to protein 
complexes at the membrane. PDZ proteins have been shown to direct multiprotein 
complexes, usually at the membrane/cytoskeletal interfaces13. There is a requirement of 
the PDZ motif for the morphological changes seen in PDGF-induced membrane ruffling, 
but it is not a requirement for tumor suppression19. While the loss of the C-terminal tail 
has seemingly little consequence for PI(3,4,5)P3 activity, emerging evidence suggests a 
role for PTEN C-terminus in the nucleus that is PI3K/Akt independent31.  
Full PTEN membrane activation requires that the short N-terminal amino acid 
sequence binds to PI(4,5)P2; unfortunately, this segment was not resolved in the crystal 
structure. This interaction with PI(4,5)P2 enhances binding and results in allosteric 
activation of the phosphatase domain8, 36-38. This sequence has been dubbed the 
phosphoinositide binding domain (PBD), and it affects the asymmetric distribution of 
PTEN in chemotaxing cells. Without the PBD, PTEN polarization is lost in these 
systems11. The sequence is conserved in mammalian, frog, worm, and fission yeast 
orthologs and is considered a putative consensus PI(4,5)P2 binding motif. Its sequence is 
Lys/Arg-X4-Lys/Arg-X-Lys/Arg-Lys/Arg and has been found in a series of actin regulatory 
proteins such as villin, gelsolin, cortactin, cortexillin and other proteins as well, 
21 
 
MARCKS19, 39-43. PTEN’s structure is designed to interact with multiple lipids in the PM. 
The project goals are to understand how these different lipids and their lateral 
organization affect PTEN’s membrane association and hence its function. 
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Chapter 2: Ensemble Kinetics 
Figure 7 shows the model that is to be tested in this thesis and presented in the 
next two chapters. PTEN is mainly a cytosolic protein. Its substrate PI(3,4,5)P3, resides 
in the inner leaflet of the plasma membrane and is rare (Figure 4). To hydrolyze the lipid, 
the protein must translocate from the cytosol to the membrane and then find the 
phosphoinositide in a complex medium (Figure 7)8, 11, 44.  
The first step of PTEN translocation to the membrane is dephosphorylation at 
S385, S380, T383, and T382. The phosphorylated state causes the C-terminal tail to fold 
back on its membrane binding surface, forcing PTEN to remain in the cytosol8, 44. The 
dephosphorylated PTEN can interact with negatively charged lipids in the PM. We 
hypothesize that PTEN’s multiple lipid binding domains synergistically interact 
with lipid membranes and efficiently localize it proximal to its substrate. Depending 
on the spatiotemporal control of the phosphoinositides and their associated lipid 
partners, this is a mechanism that could lead to the polarization of PTEN in cellular 
systems.   
In the first project, the rate constants governing the PTEN-membrane interaction 
are determined by mixing multicomponent model membranes with the enzyme and 
following membrane association over time. Fluorescence stopped-flow 
spectrophotometry will be used to investigate this reaction, and KinTeK global fit software 
will be used to process the time dependent fluorescence intensity data. This study will 
differentiate the roles of monovalent lipids like PS and PI from PI(4,5)P2 in PTEN 
membrane interactions, and consequently determine the step by step mechanism of the 
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reaction. This work is also designed to explore whether lipid domain formation affects 
PTEN binding.   
PTEN/lipid bilayer interactions have classically been explored with the lipids PS 
and PI(4,5)P2. Thermodynamic results suggest a synergistic interaction of PTEN with 
these two lipids, but the detailed mechanism of this interaction remains elusive. Kinetic 
experiments can probe the mechanism, and determine whether other anionic lipids can 
participate in the lipid bilayer/PTEN interaction. We explored an additional PTEN lipid 
C2 PD 
(+) 
C2 PD 
C2 PD (+) 
C2 PD 
PI(4,5)P2 
PI(3,4,5)P3 
PS 
PI 
PC 
Figure 7. The hypothesis model of PTEN interacting with complex model membranes. 
Dephosphorylated PTEN can interact with negatively charged membranes. The binding is synergistic 
where multiple domains PBD, PD and C2 domain, bind to different lipids correctly targeting it to plasma 
membrane-like environments. We also want to explore a sub-hypothesis where mixed lipid systems 
known to cluster PI(4,5)P2 will form an even more optimal environment for PTEN binding and solve the 
rarity paradox highlighted in figure 4. 
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binding partner, PI. PI is the precursor to all PIPs, has been found to cluster with 
PI(4,5)P29, and like PS carries a (-1) charge. In this chapter, we will explore if this lateral 
organization of PI/ PI(4,5)P2 mixing impacts PTEN’s association9. If the domains of 
PI(4,5)P2 indeed affect the rate of PTEN membrane binding, it indicates a level of lipid 
organization and influence on biology not appreciated by the classic Singer Nicolson 
model.    
2.1 Methodology 
Recombinant PTEN Expression and Purification. 
  Recombinant PTEN proteins (both native with cleavable N-terminal 6HIS tag [47.2 
kD, PI 5.94, Extinction coefficient 42020 M-1 cm-1 after removing 6HIS tag] and PTEN-
ybbr-6HIS [MW 49.4kD, PI 6.49]) were expressed in Escherichia coli BL21-(DE3) cells 
(New England Biolabs (NEB), Ipswich, New England) as per the instructions  from NEB. 
The starter culture was then inoculated (starting OD 0.06) in Terrific Broth at 37 °C until 
the OD reached 0.6-0.8. The culture was shifted to 18 °C, and protein expression was 
induced with 0.05 mM isopropanyl β-D-thiogalactodide (IPTG). After 20-22 hrs., the 
culture was harvested.  
The cell pellet (15-20g) was resuspended in 50 mL of lysis buffer (20mM HEPES, 
500M NaCl, 5mM Imidazole, 10mM β-mercaptoethanol (B-ME), 0.5U/mL DNAase, 0.75% 
TritonX100, 5mM phenylmethylsulfonyl fluoride, 10mM benzamide HCl, pH 7.5). The lysis 
suspension was homogenized by passing 30 mL portions through the French Press three 
times or until the sample was uniform in viscosity and texture. The samples were then 
spun at 18,000 rpm in a Beckmann centrifuge at 4 °C for 30 min. The supernatant was 
collected and transferred to the ultracentrifuge and spun for an hour at 45,000 rpm at 4 
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°C. The clarified supernatant was collected and kept ice cold until passage and 
purification on the FPLC. HIS6 proteins were separated from the crude supernatant by 
passing over 2x 1mL HiTrap IMAC FF column (GE).  
The purified protein was taken and pooled for the final dialysis into the working buffer 
(20 mM HEPES pH 7.4, 150 mM NaCl, 2mM EDTA, 1mM TECP). After dialysis, the 
concentration was determined using a Nanodrop UV-vis spectrophotometer (Thermo 
Fisher Scientific Waltham, MA). The PTEN concentration was determined using the 
Nanodrop A280 method as outlined by ThermoFisher as well as by carrying out a 
Bradford assay. In addition to this, the protein quality was also checked using dynamic 
light scattering (DLS) to ensure that no aggregation occurred during the purification. 
Lipid Vesicles 
To make unilamellar lipid vesicles, the appropriate amount of lipid stock solutions 
are dispensed into an amber vial. The solvent is evaporated with a gentle stream of N2 
while the sample is heated to ~30°C. The vial with the lipid film is then placed in the 
vacuum oven overnight at ~50°C. Drying the lipid mixture above the Tm of the highest 
melting temperature ensures that the lipids remain well mixed during the drying process. 
The lipid film is re-suspended in loading buffer and vortexed for 60s. This is repeated 
three times with four minutes of rest in between. The multilamellar vesicles are then 
extruded (Avanti Extrusion Kit) through a 100nm polycarbonate membrane (Avanti, 
Alabaster, Al) for a total of 31 passes. The size distribution of the resulting unilamellar 
lipid vesicles is checked by DLS. Using this method, unilamellar vesicles with a narrow 
size distribution and an average hydrodynamic diameter of ~125+/-10nm are obtained. 
These vesicle suspensions are kept no longer than 24 hours8. 
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To ensure the quality of the lipid vesicles, only small chloroform stocks of lipids are 
kept and only for a short duration. Most importantly, anionic lipids, particularly 
phosphoinositides are susceptible to hydrolysis of the headgroup at the phosphodiester 
bond. These lipids are not kept any longer than a month in an organic solvent, and when 
they are used after two weeks dissolved in chloroform, the stock solutions are checked 
for lipid degradation by TLC.  
The solvent mixtures to conduct the TLC analysis used for dansylPE, POPC, 
POPS, LiverPI are both 2:1 chloroform: methanol and 1:1 chloroform: methanol. When 
the head group is lost during degradation, you will see streaking and loss of separation 
on the plates. PI(4,5)P2 is tested against 65:25:4 chloroform:methanol: conc. ammonium 
hydroxide and 1:1 chloroform:methanol. When the PI(4,5)P2 is high quality, it migrates 
slightly above the starting line in the first mixture and fails to migrate in the second. When 
degraded, the sample fails to migrate in the first mixture and appears as a streak in the 
second. For additional information on TLC and solvent mixtures visit the Avanti Polar 
Lipids website for full technical details (www.avantilipids.com).  
Highly accurate lipid concentrations are needed for the kinetic experiments. Lipid 
concentrations in the stock solutions are determined by phosphate assay analysis 45, 46. 
In brief, samples of the lipid stock solution are measured to approximate 0.05 μmol total 
phosphate. This is compared with the phosphorus standard (0.65mM, Sigma, St. Louis, 
MO) with a concentration range from 0 μM – 114 μM. The solvent is removed with a gentle 
stream of N2. The lipid film is then subjected to 8.9N sulfuric acid and allowed to react at 
215 °C for 25 min. Then 30% hydrogen peroxide is added to the sample vials and heated 
for an additional 30 min. The samples were allowed to cool, and deionized water was 
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added. To begin the colorimetric assay, a 2.5% w/v ammonium molybdate (VI) 
tetrahydrate solution is added, and the samples are vortexed, then a 10% w/v ascorbic 
acid solution is added, and the samples are vortexed. The color is allowed to develop for 
30 mins, and the samples are added to a 96-well plate, and the absorption intensity is 
recorded at 600 nm. 
Stopped-Flow Techniques 
The SX20 stopped-flow spectrophotometer (Applied Photophysics, Leatherhead, 
Surrey, UK) determines the rate constants that govern reaction kinetics by measuring the 
temporal evolution of a fluorescence signal as a result of a chemical reaction or 
interaction. It is designed with a flow circuit comprised of two Hamilton drive syringes 
whose plungers are set against a pneumatic drive ram. For each injection, the drive ram 
pushes the reagents from the two syringes where they meet in a T-mixer. The T-mixer 
under pressure is highly efficient at mixing reagents thoroughly and quickly. The above-
described process results in a dead time of only 2 ms, allowing us to investigate rapid 
biochemical interactions. The reagents move through and are combined in the flow circuit, 
they enter the optical cell (20μL, pathlengths 10mm X 2mm) where data collection begins. 
Data collection follows the emission change over time and builds the reaction 
curves of the experiment. In our work, an emission intensity signal is collected once every 
12.5 μs. When 800 signals are gathered, they are averaged to a single intensity value, 
which is plotted against time.  This is repeated for a total of 1000 points collected over 3s 
to generate the raw data curve. In addition to these settings, for optimal data collection, 
the option for pressure hold is also selected. This tells the instrument not to release the 
drive ram pressure until after the data has been collected. This option is necessary to 
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eliminate an artifact at 0.15 ms due to the mechanical release of the drive ram. There are 
three other important ways to control the signal-to-noise ratio and ensure optimal data 
quality:  
(1) The voltage applied to the photomultiplier tubes used to collect the emission 
signal can be altered. When the PMT has a higher voltage, the electronic 
response is more sensitive to the emission signal. There is a point of 
diminishing returns though because noise will begin to increase as well. The 
voltage must be set to the optimal value for the experiments being conducted. 
This value is determined by a couple of test runs. 
For our work, we conducted two reactions at the edges of the titration range 
that was used in the association experiments.   These were 1μM PTEN with 15 
μM lipid and 1μM PTEN with 300 μM lipid (surface concentration). Please note 
that the lipid concentrations are those for the outer leaflet of the vesicle only 
(“surface concentration”) since the protein cannot access the inner leaflet lipids 
of the vesicle. The composition of the lipid vesicles was 30% POPS/ 68% 
POPC/ 2% DansylPE; this reaction is less robust compared to other vesicle 
compositions. Using these reactions as a standard, we can set the voltage at 
a value necessary to see a change in PTEN binding but will not go off scale for 
the more robust interactions. This value was 350V for dansyl emission change 
while keeping the light source and filters the same.  
(2) The light source also affects the signal-to-noise ratio. Our SX20 system is 
outfitted with a 280nm LED excitation source. The power supply allows us to 
change the output of the LED by adjusting the current from 2 mA – 20 mA. 
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Higher currents result in higher signals. The downside of high currents is 
photodamage and bleaching of the fluorophores. With our chemistry, this 
degradation was significant after 3 s of data collection at the highest LED 
current. With optimization 10 mA is the highest current within the time range of 
interest to ensure no bleaching effects.  
(3) Finally, the third option is to adjust the concentration of the reactants. In our 
experiments, our reactants are an enzyme (PTEN) and lipid vesicles. The 
source of the signal in these components are fluorescent molecules. In PTEN 
the fluorophore is intrinsic. PTEN has two tryptophans, W111, and W247. 
W111 is distal to the membrane binding surface and thus is unlikely to 
participate in the FRET transfer with the dansyl-labeled lipid. This is in contrast 
to W247 which is proximal to the membrane interface. This intrinsic fluorophore 
has an absorbance maximum that occurs at 280 nm, and its emission 
maximum ranges from 320 nm to 350 nm depending on the environment. In 
contrast to the tryptophan found in PTEN, the fluorophore DansylPE needs to 
be added to the vesicles making it an extrinsic fluorophore. For all the stopped-
flow experiments, the composition of the vesicles always contained 2% 
DansylPE. The absorption maximum is 336 nm which is in the middle of the 
PTEN emission range. This is a key aspect in choosing a good FRET acceptor.  
The emission maximum of dansyl is 515 nm8.  
The fluorescence signal is proportional to the concentration of the fluorophore as 
described by the Beer-Lambert law. We use a protein concentration of 1 μM. This 
provides a high enough signal while not being wasteful of the enzyme. For the vesicles, 
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we settled on 2% dansylPE of the mole composition of the total lipids composing the 
vesicle. This mole fraction is the minor component compared to all other lipid species in 
the vesicle, yet it was found that any less causes an unacceptable signal-to-noise for the 
lowest titration points in the experiment.   
  With our optimized settings for data collection, we run an experiment with 
our protein concentration at 1μM and measure the rate of the reaction with a series of 
vesicle concentrations for each lipid composition. This titration range is 10 μM - 250 μM 
(surface lipid). We found that above 300μM lipid concentration light scattering of the lipid 
vesicles interfered with data collection while below 25 μM, data for the weaker 
PTEN/vesicle interactions was too noisy to be analyzed with confidence. Therefore, 25uM 
is the lowest concentration used to define the rates that govern the PTEN/lipid reaction.  
KinTeK Global Fit Analysis 
 KinTek is a software developed to solve complex reaction phenomena observed 
by stopped-flow analysis. Traditionally, reaction kinetics are solved by derivatizing 
mathematical equations used to describe the reaction curve. However, the mathematics 
becomes non-trivial for complicated multi-step reversible reactions. To avoid this, 
analytical solutions can be derived by making simplifying assumptions and setting up 
reactions so that the substrate is in great excess of the enzyme. The result is that during 
the reaction most of the substrate is not participating, meaning the initial substrate 
concentration remains unchanged resulting in a pseudo first order reaction condition. 
Unfortunately, there are many times that a reaction needs to be done at approximate 
concentrations, resulting in a scenario where the simplifying assumptions are invalid. In 
addition to this, the tradition analytical method relies on a summation of exponential 
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functions, where each phase is matched to a rate constant. There are multiple examples 
where vital information is lost. One example is an enzyme known as ESPS, which shows 
a biphasic exponential response, where actually there are a total of six steps, not just 
two47.  
 An approach to this difficult data analysis is to use a global fit software, KinTek, 
where the data set can be fit directly to a hypothesized kinetic model. This particular 
software allows formulation of the model with text. The software then defines the 
derivation and solves the reaction kinetics by numerical integrations determined by the 
values defined by the starting concentrations of the reactants, the signal output to define 
the data, (in our case the dansyl emission increase due to FRET) and the time course 
over which the reaction occurs.  
  A downside is that this type of data analysis can lead to an overly complex model. 
To address this, the software is designed to allow multiple experiments to be fit with the 
same model. Also, if a rate constant is explicitly known or the relationship between two 
rate constants (for example, a known equilibrium constant) are known, these can be held 
or linked, thereby constraining the results.  
 This global fit program utilizes multiple methods to determine the constraint and 
the accuracy of the results.  For example, the standard error is calculated based on 
nonlinear regression fits. Unfortunately this method fails to reveal to what extent the fitted 
parameters are under constrained when the model is overly complex.  Nonlinear 
regression is based on the well-established equations for linear regression by proposing 
that the best fit is defined by the parameter set resulting in the minimum sum squared 
error. In fact, this method tends to push the parameters to values where they no longer 
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affect the curves. To avoid these pitfalls, KinTek allows you to graphically inspect the 
constraints of the parameters to better understand the relationships between them and 
test the constraint of the found values.  
2.2 Ensemble Kinetics of PTEN binding to Lipid Membranes 
 The emission intensity of dansylPE increases over time as PTEN binds to 
the lipid vesicles due to Förster resonance energy transfer (FRET). FRET is a 
phenomenon where one fluorescent molecule donates its excited energy to an accepting 
molecule. FRET is a radiation-less transfer, which occurs through resonance. The 
accepting molecule can either be capable of fluorescence or not. It is this distinction why 
Förster resonance energy transfer (FRET) or resonance energy transfer (RET) is the 
correct nomenclature rather than the incorrectly used fluorescence resonance energy 
transfer. In the case of this work, we have chosen an acceptor capable of fluorescence. 
It is a useful tool to study interactions since this transfer only occurs at very short 
distances and the two molecules must meet specific physical characteristics. There are 
three major physical parameters that determine if the FRET transfer occurs and if it does, 
the efficiency. These parameters are spectral overlap between the donor and the 
acceptor, dipole alignment and the distance between the two molecules. The FRET 
transfer efficiency as related to distance as shown in equation 148, 
𝐸 =
1
1+(
𝑟
𝑅0
)6
 ,                                                         Eq 1. 
where (r) is the distance between the donor and the acceptor, and (R0) is the Förster 
distance. The Förster distance is the distance between the FRET pairs where there is 
50% transfer efficiency. In the case of this system, PTEN carrys the donor (tryptophan 
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247, W247) and the vesicle has the acceptor (dansylPE, 2% mol fraction).  The Förster 
distance for this pair is 21-24Å. Since transfer efficiency drops off rapidly with increasing 
distance (equation 1), FRET works as a switch in our experiments. In other words, there 
is only transfer if the protein interacts with the surface of the membrane.  
Figure 8 shows an example of stopped-flow data using the two detector system. 
With this setup, we could technically follow the change of emission for both fluorophores 
as a function of time. As expected, there is a decrease in the emission of W247 and an 
increase of the emission of the dansyl-PE. Of the two fluorescence intensity curves, the 
dansyl-PE emission has a far superior signal-to-noise ratio. Also, the W247 curve shows 
a significant downward slope which never comes to equilibrium, even over a period of 
hours. For these reasons, all further data analysis was done on the acceptor emission 
response to PTEN binding.  
In all these data, there is a slight linear slope seen at longer times that consistently 
has a value equal to 0.001+/- 0.0005 for the dansyl-PE emission curves. It is negative for 
the dissociation experiment and positive for the association experiment. This could be 
due to the complicated nature of vesicle light scattering and slow aggregation overtime 
(a documented feature of anionic lipid-containing vesicles)49. Another thought was that 
while the protein and membrane interaction can reach equilibrium quickly (PTEN moving 
from the aqueous environment to the membrane) there may be a slow rearrangement of 
the lipids that affects the dansylPE environment. The lateral movement of lipids is about 
100 times slower in the membrane compared to a particle in aqueous solution. It is also 
known that PTEN does cause rearrangement of its binding lipids when it interacts with 
the surface9. These two phenomena, vesicle fusion and slow lateral lipid movement, 
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make the long time scale kinetic information complicated, its nature (exact origin) is ill 
defined and is beyond the goal of these experiments. What is important to note is that the 
simple addition of a linear slope fits the data and consistently results in the same value 
independent of the type of vesicle composition.  
 FRET only occurs when PTEN binds to anionic lipids or PI(4,5)P2. Figure 9 shows 
data comparing PTEN interacting with vesicles at the same concentration but with varying 
lipid compositions. The PC only vesicles show no dansyl-PE emission; only when vesicles 
contain at least one type of anionic lipid or phosphoinositide is there a change in signal.  
Most studies in the literature solely report kinetic data for proteins interacting with vesicles 
Figure 8.  FRET transfer between PTEN W247 and dansyl-PE when PTEN binds to a vesicle 
composed of 5% PI(4,5)P2, 2% DansylPE, 93% PC. The dansyl emission intensity increases as the 
tryptophan (W) emission intensity decreases through time. For the kinetic experiments, we choose to 
follow the dansyl emission intensity change because, in comparison to the W emission, the data had a 
superior signal to noise ratio.  
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with simple lipid compositions. Since our goal is to determine the rate constants governing 
PTEN interactions with various lipids, our study needs to be extended beyond this general 
approach. To our knowledge, this type of kinetic work with multicomponent lipid vesicles 
and nuanced pre-steady state kinetics has not been thoroughly described in the literature. 
To take care in interpreting our data and to avoid over-interpretation, we will use two 
methods of data analysis. First, we use an analytical method where the experiment is set 
up under pseudo-first order conditions. Second, we use the global fit software, KinTek, a 
more sophisticated analysis, which should produce more accurate rate constants. With 
these two techniques, we hope to determine the effects of lipid composition on the 
mechanism of PTEN binding as well as provide a standard for the field for analyzing 
kinetic data for proteins binding to complex lipid systems.   
Titrating vesicles into PTEN results in a range of rates dependent on reactant 
concentration (Figure 10). Each of these curves fits to the function in equation 250-52. 
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  𝑅𝑎𝑡𝑒 = 𝐴 ∗ (1 − 𝑒−𝑘𝑜𝑏𝑠∗𝑡) + 𝑚 ∗ 𝑡 + 𝐶 ,                   Eq2. 
where (A) is the amplitude, (kobs) is the observable rate, and (m) is the correction factor 
and (t) is time. The kobs is dependent on the lipid concentration; this informs us that this 
is at least a second-order reaction. The relationship of kobs to the true rates constants 
governing the reaction is  shown in equation 350-52.  
𝑘obs = 𝑘on ∗ [𝐿𝑖𝑝𝑖𝑑] + 𝑘off,                                        Eq.3 
(kon) is the assocation rate constant of the reaction, ([Lipid]) is the lipid concentration and 
(koff) is the dissociation rate constant. To discriminate between the values of kon and koff 
with the analytical method, kobs is plotted as a function of lipid concentration (Figure 11) 
Figure 10. Stopped-flow dansyl-PE fluorescence intensity curves upon PTEN binding to mixed 
PI/PC vesicles. The experiment is carried out under pseudo-first order conditions where the lipids are 
in excess. Each curve represents a different lipid concentration of the mixed vesicle composed of 
30%PI, 2%DansylPE 68%PC mixed with 0.5μM PTEN. The concentration series spans 15uM-250uM 
surface concentration (the concentration in the inset are normalized to the mole fraction of PI). The 
titration for each vesicle composition was repeated at least three times. The slope was determined from 
the exponential fit shown in equation 2. This slope is the kobs.   
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and fit to equation 3. The shape of this titration curve can inform us whether the reaction 
is rate limiting or not. Figure 11 illustrates this; if the curve is linear (blue), that indicates 
a nonrate-limiting process. If the data is nonlinear it indicates a rate-limiting step was 
captured in the experiment. For the simple binding in our case, all the data show strong 
linear trends. An example of the fit is shown in Figure 12 with PTEN mixed with 30% PI, 
2% DansylPE, 68% PC.  
The kon is dependent on the concentration of vesicles. For the kinetic analysis of 
protein binding to multicomponent lipid vesicles, a general problem is which concentration 
to use for the lipid concentration. There are four principal ways to account for the lipid 
concentration in equation 3. (1) We could use the total surface lipid concentration 
zwitterionic plus anionic lipid concentrations), (2) we could consider only the combined 
concentration of all anionic lipid species (excluding zwitterionic lipids), (3) we could 
normalize the anionic lipid concentration to the total charge (PI and PS are (-1), PI(4,5)P2 
k
o
b
s
 (
s
-1
) 
Concentration of Lipid (μM) 
Figure 11. General graph showing the difference between a rate limited, two-step reaction 
(red), and a one-step reaction (blue). This is determined by plotting kobs from a titration experiment 
as shown in Figure 10 against the concentration of lipid.  
.  
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is ( -4)), or (4) we could only take into account the major anionic lipid that participates in 
PTEN binding, i.e., target lipid concentration. Each approach has its pitfalls but also 
provides valuable information about the system. We used a holistic method and choose 
to analyze the data with all four concentration approaches. 
Kinetic analysis of PTEN association using the total lipid concentration (Figure 13) 
The PTEN on-rates using the total lipid concentration for the analysis are given in 
Figure 13.  There is little difference between the association rates in the majority of 
compositions explored. We will first compare the lipid vesicle systems with only one 
anionic lipid species present in the lipid mixture. For the single negatively charged lipids 
PS and PI, we find essentially the same on rates independent of their surface 
concentration.  For 98% PS or 98% PI the kon is 0.22-0.26 (μM-1s-1). The physiologically 
Figure 12. Rate constant kobs as a function of lipid concentration, (anionic 
component), of vesicles composed of 30%PI 2%DansylPE, 68%PC. The data are fit to 
equation 3 where kon and koff are derived. Each of these graphs are an average of at least 
three different titrations.   
Anionic Component (μM) 
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more relevant cases, 30% PS and 30% PI, have similar kon-values.  Unlike these two 
systems, 5% PI(4,5)P2 shows a slower on-rate (0.18 (μM-1s-1)). While the on-rate for this 
system is lower than the other single anionic lipid systems (though technically the error 
bars overlap), the total anionic lipid concentration in the PI(4,5)P2 containing vesicle is 
significantly lower. The comparison of the binary anionic lipid systems reveals some 
differences between the PS and PI-containing vesicles. Comparing 30% PI/ 5% PI(4,5)P2 
to 30% PS/ 5% PI(4,5)P2, we find that the PI system has a slower on-rate of 0.12 (μM-1s-
1) compared to the PS system at 0.2 (μM-1s-1). This trend is repeated in the 10% PI/ 1% 
PI(4,5)P2 vs. 10% PS/ 1% PI(4,5)P2 case but overall the on-rate values are lower (0.08  
(μM-1s-1) for PI/ PI(4,5)P and 0.12 (μM-1s-1) for PS/ PI(4,5)P2. PTEN binding to PS only 
vesicles in comparison to PI only vesicles shows little difference in the on-rates, but when 
these anionic lipids are mixed with PI(4,5)P2, a slower association rate is observed for the 
Figure 13. Comparison of kon rates derived from the analytical method using total surface lipid 
concentration in the analysis of PTEN binding to mixed lipid systems. 98% PS, 98% PI, 30% PS, 
and 30% PI have an average kon rate of 0.2 μM-1 s-1. 5% PI(4,5)P2 is slower with a rate of 0.15 μM-1 s-1. 
The multicomponent vesicles have a slower rate compared to the PS and PI single component models. 
Also, the multicomponent models favors a faster rate with PS containing vesicles compared to PI; 10% 
PS/ 1% PI(4,5)P2 rate is 0.12 μM-1 s-1; 10% PI/ 1% PI(4,5)P2 rate is 0.08 μM-1 s-1; 30% PS/ 5% PI(4,5)P2 
rate is 0.18 μM-1 s-1; 30% PI/ 5% PI(4,5)P2 rate is 0.12 μM-1 s-1.  
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PI/PI(4,5)P2 vesicles in comparison to the mixed vesicles containing PS. Another 
observation is that the binding kinetics of PTEN to vesicles with 30% PS or 98% PS is 
similar, suggesting a limiting effect of the overall surface charge (number of charged 
lipids) and the rate of PTEN binding. A surprising result is the observation that PTEN 
association with binary anionic lipid vesicles is slower than for vesicles with a single 
anionic lipid (see 30% PI vs. 30%PI/ 5%PI(4,5)P2). We believe this is due to differences 
in the lateral lipid distribution (domain formation) of the systems resulting in crowding 
effects of surface-bound PTEN. 
Kinetic analysis of PTEN association using only the concentration of the anionic lipid 
species (Figure 14) 
One has to be careful when interpreting the data obtained through a kinetic 
analysis base d upon the concentration of only the anionic lipid component because lower 
concentrations skews the result towards faster kon rates. This is exemplified when 
comparing the kon rates for 98% anionic lipid (PS or PI) to 30% anionic lipid (PS or PI). 
While we found the kon values to be the same when the total lipid concentrations are used, 
we found when we normalize the concentration to the mole fraction of anionic lipid the 
rates for 30% anionic lipid are faster than for 98% anionic lipid. The primary reason is that 
the unit of the rate constant is µM-1s-1, i.e., a lower concentration will lead to a higher rate 
constant. Nevertheless, some valuable information can be extracted from such an 
analysis. Using this approach, PI(4,5)P2  emerges as a very potent PTEN binding partner 
(see Figure 14) since its kon in the presence of PI(4,5)P2 is by far the fastest. For the other 
vesicle systems with only one anionic species, 30% anionic lipid (PS or PI) shows a faster 
association when compared to 98% anionic lipid (PS or PI), but again the chemical identity 
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of the monoanionic lipid does not seem to matter. 10% PS/ 1% PI(4,5)P2 shows an 
association on par with 30% monoanionic vesicles, whereas 10% PI/ 1% PI(4,5)P2 
exhibits a slower PTEN association rate than the corresponding 30% PI vesicles. Finally 
30% PS/ 5% PI(4,5)P2 and 30% PI/ 5% PI(4,5)P2 show the second slowest association, 
underscoring the observation we made in the previous section that the binary lipid 
systems exhibit slower association rates presumably due to an altered lipid distribution. 
The take home message of this analysis is that PI(4,5)P2 is a more potent PTEN binding 
partner compared to the single charged anionic lipids. These data furthermore support 
the previous observation that there is an upper limit to increasing surface charge as 
highlighted by the reduced association rates for 98% anionic lipid.   
Figure 14. Comparison of the anionic component kon derived from the analytical method of PTEN 
binding to lipids. 5% PI(4,5)P2 shows the fastest rate at 3.2 μM-1 s-1. 98% PS and 98% PI rate is 0.2 
μM-1 s-1, but 30% PS and 30% PI are more potent and have an average kon of 0.54 μM-1 s-1. The 
multicomponent vesicles are more comparable to the 30% single models. The multicomponent models 
still favors a faster rate with PS containing vesicles compared to PI; 10% PS/ 1% PI(4,5)P2 rate is 1.2 
μM-1 s-1; 10% PI/ 1% PI(4,5)P2 rate is 0.54 μM-1 s-1; 30% PS/ 5% PI(4,5)P2 and 30% PI/ 5% PI(4,5)P2 
rate is 0.5 μM-1 s-1.  
Anionic Component 
42 
 
Kinetic analysis of PTEN association using a charge normalized lipid concentration 
(Figure 15) 
When the data is analyzed by normalizing the anionic lipid concentration with the 
charge of the respective lipid, we account for PI(4,5)P2 exhibiting a significantly higher 
charge (and hence electrostatic potential) than the other anionic lipids (PS and PI). To 
calculate the mol% of these vesicles 10% PS/ 1% PI(4,5)P2 would account for 14% of the 
total lipid with PS having (-1)  valence and PI(4,5)P2 with (-4) valence. Looking at the 
single anionic lipid vesicles, we see that 30% PS, 30% PI and 5% PI(4,5)P2 (20% valence 
charge) all have the same association rate. 98% PS or 98% PI still shows a reduced rate 
in comparison to the other systems despite the increased surface potential. This supports 
the hypothesis that there is an upper limit to the effect of the surface charge on PTEN 
Figure 15. Comparison of the charged normalized kon derived from the analytical method of PTEN 
binding to lipids. 5% PI(4,5)P2 (20% valence charge), 30% PS, and 30% PI have the same  kon of 0.78 
μM-1 s-1. The multicomponent models still favor a faster rate with PS containing vesicles compared to 
PI. The lower potential system, 14%, as compared to the 50% system has a faster kon; 10% PS/ 1% 
PI(4,5)P2 rate is 0.78 μM-1 s-1; 10% PI/ 1% PI(4,5)P2 rate is 0.5 μM-1 s-1; 30% PS/ 5% PI(4,5)P2 and 30% 
PI/ 5% PI(4,5)P2 rate is 0.3 μM-1 s-1.  
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binding. When comparing multicomponent vesicles, there are significant differences 
between 10% PS/ 1% PI(4,5)P2 and 10%PI/ 1% PI(4,5)P2 with the PS/ PI(4,5)P2 vesicle 
having a faster PTEN association. This trend continues with 30% PS/ 5% PI(4,5)P2 and 
30% PI/ 5% PI(4,5)P2  though it is not as dramatic and not at a statistically significant level. 
Again, we highlight that at a 50% surface valence composition the association is reduced. 
Kinetic analysis of PTEN association using the “target” lipid concentration (Figure 16) 
The final way to analyze these data is to explore the rate constants using “target” 
lipid concentration for the kinetic analysis. The target lipid is defined as the lipid that 
makes the strongest interaction with PTEN when in mixed systems. For the vesicle 
systems with only one anionic lipid, the target lipid is that anionic lipid. For vesicles with 
two anionic lipids, it is PI(4,5)P2. The reasoning is PI(4,5)P2 interacts with PTEN 
specifically via hydrogen-bond formation, which should be stronger than pure electrostatic 
interactions. The chemistry matters in this type of interaction, meaning that the other 
bisphosphate-phosphoinositides PI(3,4)P2 and PI(3,5)P2 cannot replace PI(4,5)P2. This 
is in contrast to the non-specfic electrostatic interactions seen with PS or PI. Here, either 
lipid is just as good as the other when they are in single anionic component vesicles.  
Focusing first on the lipid vesicles with a single anionic lipid, the fastest association 
is seen with 5% PI(4,5)P2 followed by 30% anionic lipid and then 98% anionic lipid. 
Obviously, this is the same result we obtained in Figure 14 where we accounted only for 
the anionic lipid species. The 10% PS/ 1% PI(4,5)P2 vesicle system shows the fastest 
PTEN association rate followed by 10% PI/ 1% PI(4,5)P2 then 30% PS/ 5% PI(4,5)P2 and 
finally 30% PI/ 5% PI(4,5)P2. These data magnify the difference between the PS and PI 
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lipids in the multicomponent anionic lipid vesicles. In these mixed lipid systems, the PS-
containing vesicles showed a faster PTEN association rate than the vesicles with PI.      
Looking at the graphs holistically we can come to some conclusions about PTEN 
association with mixed lipid vesicles.  When we account for the total available lipid PC/ 
PS/ PI(4,5) P2 like we did in the first analysis; we are essentially testing the effects of 
vesicle type on PTEN association. If the association of PTEN was only affected by the 
total surface potential, we would expect the bars to trend with increasing charge. While 
we see this slightly between 5% PI(4,5)P2 and the 30% anionic lipid, PTEN binding 
appears to saturate at higher anionic lipid concentrations. The data that are shown in 
Figure 13 illustrate that PTEN lipid binding kinetics is not simply proportional to the surface 
Figure 16. Comparison of the kon values when using the target lipid concentration for the kinetic 
analysis method of PTEN binding to lipids. 5% PI(4,5)P2 has the fastest kon of the single component 
anionic vesicles at 3 μM-1 s-1,  followed by 30% PS and 30% PI with a  kon of 0.78 μM-1 s-1 followed by 
98% PS and 98% PI at 0.2 μM-1 s-1. The overall fastest binding is 10% PS/ 1% PI(4,5)P2  with a rate of 
12 μM-1 s-1 followed by 10% PI/ 1% PI(4,5)P2 with a rate of 7.5 μM-1 s-1 then 30% PS/ 5% PI(4,5)P2 at 
3.5 μM-1 s-1 and finally 30% PI/ 5% PI(4,5)P2 with a rate of 2.5 μM-1 s-1. This method of analysis highlights 
the difference between the PS and PI in multicomponent vesicles. In both cases, PS has a faster rate 
compared to PI which is not apparent with the single component vesicles.  
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potential. The kon values presented in Figure 14 utilized only the concentration of the 
anionic lipid component(s) since PC is not participating in the binding of PTEN (Figure 
10). These data highlight that PI(4,5)P2 is a more potent binder than either PS or PI. When 
these single charged lipids are mixed with PI(4,5)P2, a decrease in the PTEN association 
rate is observed. This suggests that the complex morphology of these ternary lipid 
vesicles impact the kinetics of PTEN binding. This underscores earlier findings by our 
group9, 36, 53-55 that PTEN binding to anionic lipids and PI(4,5)P2 is highly synergistic.   
To ensure that the observed effect of PI(4,5)P2 on PTEN binding is not just from 
the increased charge of the lipid in comparison to the other anionic lipid species, we also 
investigated the PTEN association rates as a function of total valence charge (Figure 15). 
Here 5% PI(4,5)P2, 30% PS, and 30% PI showed little difference, whereas the 98% PI or 
98% PS vesicle systems showed a decreased PTEN association rate. The trend of PTEN 
binding to PS/ PI(4,5)P2 having a faster association rate than the PI/ PI(4,5)P2 system is 
also found for this analysis approach.  
This may suggest that when there is a single component anionic vesicle, the 
protein is driven to the vesicle surface through electrostatic interactions and hence the 
overall negative potential as defined by the total valence charge of the lipid(s). And this 
potential will determine the kon-rates. However, above ~30-40% anionic lipid, an 
increased overall surface potential will not increase the kon-rates, i.e., the system 
apparently reaches saturation (as evidenced by the slower rate for 98% anionic lipid). 
This is in contrast to when there are multiple lipid-binding partners; the association is no 
longer determined strictly by the surface potential. 
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Lastly, we analyzed the kinetic data by using the target lipid concentration as input 
for the calculation of the kon-rates. In the single anionic lipid cases, it is just the mole 
fraction of the anionic lipid. For the mixtures, we focus only on PI(4,5)P2. Here we see the 
fastest association with 10% PS/ 1% PI(4,5)P2 followed by 10% PI/ 1% PI(4,5)P2. 5% 
PI(4,5)P2 and 30% PS/ 5% PI(4,5)P2 are next then 30% PI/ 5% PI(4,5)P2 and finally 30% 
anionic lipid with 98% anionic lipid being the slowest. This again demonstrates that 
PI(4,5)P2  has a role beyond being an electrostatic contributor. If this were the case, we 
would expect the combination of lipids PI(4,5)P2/ anionic lipid to change with the overall 
potential.  
The data for vesicle systems with anionic lipid/PI(4,5)P2 show that PTEN gets to 
the interface through electrostatic interactions and “something else.” Some of this is, of 
course, due to the more potent (-4) charge of PI(4,5)P2 but the interaction of PTEN with 
these mixed systems is also affected by the second anionic lipid. The data for the single 
anionic lipid vesicles show that only up to a certain total potential PTEN association rates 
increase. The lack of increase of association rate with increasing surface potential 
indicates that there may be surface crowding effects on the vesicles that inhibit PTEN 
binding. This surface crowding may also be a contributing factor for the decrease in PTEN 
association rates in the anionic lipid/PI(4,5)P2 vesicles. This is highlighted in the 
difference between PI and PS mixed PI(4,5)P2 vesicles. There is evidence that PI clusters 
PI(4,5)P2 into domains.9 We originally thought that this clustering would cause an increase 
in local potential and therefore, would drive the protein faster to the surface. These data 
show the opposite. In a scenario where there is a domain of PI(4,5)P2, with 20 to 50 lipids, 
the protein may only bind to a few them, however, due to the footprint of the protein a 
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significantly larger fraction is covered and inaccessible to other PTENs. As a result, there 
is a reduction in the number of binding sites available for other PTEN molecules.   Protein 
crowding is also highlighted in the vesicles that have 30% anionic lipid vs. 98% anionic 
lipid. Somewhere around 30 mol% charge there is a limit at which the surface area is 
maximally covered by this protein, and thus any further increase in overall charge will not 
affect PTEN’s rate of association. An important outcome of our analysis of PTEN 
association rates with various mixed vesicles is that any procedure one might choose in 
terms of lipid concentration will overestimate the amount of lipid binding partners available 
for the protein molecules to bind to. In other words, for surface morphologies with 
clustered lipids, the kon-values are a low estimate of the actual kon-values since the 
amount of effective lipid concentration available for binding is lower than the calculated 
lipid concentration (irrespective of the method that is being used for the analysis)   
Kinetic analysis of PTEN dissociation from mixed vesicles 
The data in Figure 17 shows the dissociation rate constant (koff) determined by the 
analytical method (Figure 12, equation 3). With koff, a high rate is synonymous with the 
protein quickly falling off the vesicle, while a low or small rate indicates strong binding. 
The dissociation data reveals more pronounced differences between each of the lipid 
vesicle compositions. Whereas before the vesicles with 30% anionic lipids (PI or PS) vs. 
98% anionic lipids (PI or PS) showed no difference in the association rate constants; there 
is a dramatic difference observed for the dissociation rate constants. The vesicles with 
the higher concentration of anionic lipids (PI or PS) show a considerable stabilization of 
the wtPTEN/vesicle interaction. While there was virtually no difference found for the PTEN 
association rate constant for the anionic lipid PI vs. PS, we find an additional stabilization 
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Figure 17. Comparison of the koff values derived from the analytical method (Figure 12, eq. 3) of 
PTEN binding to lipids. The stability of PTEN binding to single anionic component vesicles trend with 
surface potential. Binding to 30% PS and 30 % PI is the weakest, but there is also a stabilizing effect 
with the PS vesicle. This trend is also recapitulated with 98% single component anionic lipids. The koff 
value for PTEN binding to 5% PI(4,5)P2  is almost as low as it was found for the 98% anionic lipid 
vesicles, suggesting that PI(4,5)P2 interacts more strongly with PTEN than the single valence lipids. 
This idea is further supported in the 10% PI/ 1% PI(4,5)P2 and 10% PS/ 1% PI(4,5)P2 vesicles. By far 
the strongest binding is found for 30% PS/ 5% PI(4.5)P2 and 30% PI/ 5% PI(4,5)P2, which exhibit 
significantly slower dissociation rates than 98% anionic lipid binding scenario. 
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of PTEN association with the PS lipid. This may suggest that the PS/PTEN system is not 
purely non-specific electrostatic but also has a minor contribution that is specific for PS. 
In other words, our hypothesis that PS is fully replaceable by PI seems to be incorrect 
based on these data (see below for further discussion).  The rate constant for PTEN 
dissociation from 5% PI(4,5)P2/ PC vesicles has a value between the 30% and 98% single 
anionic lipid vesicles, highlighting how much more potent PI(4,5)P2 is in stabilizing the 
PTEN/vesicle interaction.  
 Significant differences are observed for PTEN’s interaction with PI(4,5)P2/ anionic 
lipid (PS or PI)  mixed vesicles. For 30% anionic lipid (PS or PI) with 5% PI(4,5)P2 there 
is a dramatic increase in the stability of PTEN binding. This is less pronounced for vesicles 
with 10% anionic lipid and 1% PI(4,5)P2. These results highlight three fundamental 
properties of the PTEN/anionic lipid/PI(4,5)P2 complex: First, PTEN requires a minimal 
charge density for binding; apparently the 10% anionic lipid/1% PI(4,5)P2 does not 
provide an electrostatic environment that supports robust binding. Second, while PTEN 
binds more stably to vesicles with PS as the single anionic lipid than it binds to vesicles 
with PI as the only anionic component, this preference for PS is not observed in vesicles 
that also contain PI(4,5)P2. In fact, for the 10% anionic lipid/1% PI(4,5)P2  vesicles there 
might be a slight preference for the PI-containing system (presumably due to PI/PI(4,5)P2 
domain formation). Third, even a modest amount of the PI(4,5)P2 dramatically increases 
the stability of the PTEN-vesicle complex. While we found preferential binding of PTEN 
to 30% PS over 30% PI vesicles and concluded that PI could not fully replace PS in the 
interaction of PTEN with the membrane, we find for the binary anionic lipid system that 
binding to PI/ PI(4,5)P2 vesicles is at least as good (and probably better) than binding to 
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PS/ PI(4,5)P2 vesicles. We hypothesize that the PI/ PI(4,5)P2 domain formation offsets 
the slightly less favorable direct binding of PTEN to PI in comparison to PS.  
Equilibrium analysis of PTEN binding to mixed lipid vesicles 
We next combine these data sets to obtain Kd values for PTEN binding. Kd values 
obtained through a kinetic analysis are not true equilibrium constants since equilibrium 
constants are a thermodynamic quantity and thus must be measured with a 
thermodynamic experiment. This is because our kinetic experiments do not capture every 
binding step and environmental change that occurs as the system reaches equilibrium. 
For example, we have set up the experiment to follow the binding of PTEN and lipid, but 
we know from IR studies that there is a protein conformation change which is difficult to 
account for in these kinetic experiments36. The values we are reporting are therefore not 
“TRUE” thermodynamic equilibrium constants that account for all the changes in our 
system. Nevertheless, the trends of the Kd values seen here are close to what has been 
previously reported, (Table 3), in our lab as well as our collaborator's lab. 
Figure 18 shows the Kd values using the different lipid vesicles analyzed with the 
total lipid concentration (i.e., including the PC concentration). Again, we are primarily 
looking at the compositions as a type of vesicle and not distinguishing between which 
lipids PTEN can interact with. Analyzing the single anionic component vesicles from 
strongest to weakest it follows 98% anionic lipid, 5% PI(4,5)P2, and then 30% anionic 
lipid. The multicomponent vesicles show that 30% anionic lipid/ 5% PI(4,5)P2 has 
remarkable strong binding whereas PTEN binding to 10% anionic lipid/ 1% PI(4,5)P2 is 
fairly weak. These data illustrate that the binding is driven by the stability of the complex 
as determined by the koff.  
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Redfern et. al. Tryptophan Quenching Total Lipid Kd (μM) 
5% PS, 93% PC, 2% PyrenePE 508 +/-13 
25% PS, 73% PC, 2% PyrenePE 259 +/- 20 
5% PI(4,5)P2, 93% PC, 2% PyrenePE 163 +/- 6 
10% PI(4,5)P2, 88% PC, 2% PyrenePE 72 (error not reported) 
5% PS, 5% PI(4,5)P2, 88% PC, 2% PyrenePE 41.1 +/- 4.8 
Figure 18.  Kd values of PTEN binding to various vesicles (total lipid concentration). These data 
were analyzed using the total lipid available and were determined by dividing koff/kon. The strongest 
interactions are 30% PS/ 5% PI(4,5)P2  and 30% PI/ 5% PI(4,5)P2. The closest set is the 98% anionic 
lipid, which is 10-fold weaker than 30% PS/ 5% PI(4,5)P2. 5% PI(4,5)P2 which has a value 20-fold 
weaker than the multicomponent lipid model. This supports the hypothesis that the mixture of anionic 
lipid and phosphoinositide interacts with PTEN synergistically.   
Table 3. Thermodynamically determined Kds of PTEN binding to multicomponent lipid 
vesicles35. 
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Figure 19 normalizes the results to the total anionic lipid for the Kd calculation (i.e., 
PC component excluded). For the vesicles with a single anionic lipid, we see that the 
difference between PTEN binding to the PI and PS containing vesicles becomes more 
defined (though technically the difference between Kd values for the 30% PS vs. 30% PI 
is not statistically different), whereas PTEN binding to 5% PI(4,5)P2 is strong. The trend 
that is seen in the anionic lipid/PI(4,5)P2 combination vesicles follows the trend as seen 
for the Kd values obtained by the total lipid analysis. 30% anionic lipid/ 5% PI(4,5)P2 has 
the most potent binding, though the gain in binding strength over the 5% PI(4,5)P2 single 
component system is less pronounced. PTEN binding being stronger when mixed with 
the PS/ PI(4,5)P2 system than when mixed with the PI/ PI(4,5)P2 system is maintained 
with this analysis.  
Figure 19.  Kd values of PTEN binding to vesicles analyzed by using only the anionic lipid 
concentration. The strongest interactions are still 30% PS/ 5% PI(4,5)P2  and 30% PI/ 5% PI(4,5)P2. 
Followed by 5% PI(4,5)P2, though the difference is not as significant as total lipid. This is followed by 
98% anionic lipid than 30% anionic lipid. The trend where PS has a stronger interaction held in this 
analysis.    
Anionic Component 
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 In  Figure 20 , we account for the differences between the valence charges of the 
lipids, where PS/ PI have a (-1) charge, and PI(4,5)P2 has a (-4) charge. This translates 
for a 5% PI(4,5)P2 vesicle to (-20) surface charge/ vesicle, and 30% PS/ 5% PI(4,5)P2 
vesicle would be (-50). Despite considering the higher charge, 5% PI(4,5)P2 has a binding 
which is still stronger than we find for 98% anionic lipids. This indicates that there is 
additional stability engendered to the complex from PI(4,5)P2 beyond increased potential. 
This interpretation continues to support the hypothesis that PTEN interaction with 
PI(4,5)P2 and anionic lipids is a synergistic binding.  
  Fgure 21 is calculated using the target lipid contribution; this drives home the effect 
of PI(4,5)P2 on PTEN binding. We examined the binding considering only the target lipid 
(strongest PTEN/ lipid interaction). This means for a single anionic lipid vesicle the anionic 
Figure 20.  Compares the Kd values of PTEN binding vesicles analyzed by total valence 
contribution. The strongest interactions are still 30% PS/ 5% PI(4,5)P2  and 30% PI/ 5% PI(4,5)P2. 
These interactions are followed by 5% PI(4,5)P2, but this is now on par with 98% anionic lipid. This is 
followed by 98% PI and then 30% anionic lipid. The trend where PS has a stronger interaction held in 
this analysis. This suggests that when PI(4,5)P2 is on its own its (-20) anionic charge is on par with a (-
98) single valence anionic vesicle. This again shows how potent a binder PI(4,5)P2 is compared to 
traditional anionic lipids. 
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lipid concentration is used. For the multi-anionic component vesicles, we report only the 
mol fraction of PI(4,5)P2. This is most clearly seen when comparing 5%PI(4,5)P2 and the 
1% PI(4,5)P2/ 10%  anionic lipid. Here the addition of the anionic lipid makes 1% PI(4,5)P2 
comparable to 5% PI(4,5)P2  vesicle. The addition of 30% anionic lipid to  5% PI(4,5)P2 
dramatically increases the binding, in particular, PS makes the interaction 21 times 
stronger.  
What have we learned from the analysis of the kinetically derived Kd values? First, 
the data displayed the same trends in PTEN binding strengths as was previously found 
by using thermodynamic methods (Table 3). Second, PTEN appears to show stronger 
binding to the PS /PI(4,5)P2 system than to the PI/ PI(4,5)P2 system. This is rooted in the 
faster PTEN association with the PS/ PI(4,5)P2 containing vesicles (the dissociation of 
Figure 21.  Compares the Kd values of PTEN binding to vesicles analyzed by target lipid 
concentration. The target lipid analysis singles out the contribution of PI(4,5)P2 in the mixed anionic 
lipid vesicles. With the equilibrium constants we see that the strongest binding is with 30% PS/ 
5%PI(4,5)P2 followed by 30%PI/ 5% PI(4,5)P2.30 PS/ 5%PI(4,5)P2  is 21 times stronger than 10%PS / 
1%PI(4,5)P2 and 30% PI/ 5%PI(4,5)P2 is about 13 times stronger than 10% PI/ 1% PI(4,5)P2. Another 
interesting comparison to make is that 5% PI(4,5)P2 has the same binding constant as 10% PS/ 
1%PI(4,5)P2 and is a little stronger than 10% PI/ 1%PI(4,5)P2.    
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PTEN from the PI/ PI(4,5)P2 is, at least for the 10% anionic lipid system, slower than for 
the PS/ PI(4,5)P2 system). As noted above, the slower PTEN association to the PI/ 
PI(4,5)P2 is most likely due to lipid clustering and the associated limitation of accessible 
lipid. This highlights the difficulty in comparing protein binding to vesicles with complex 
lipid compositions and morphologies. Based on the kinetic data presented above and the 
calculated Kd values, it might be that the best measure of the protein binding strengths 
are the dissociation rates since they are mathematically independent of lipid 
concentration.   
2.3 Global Analysis. 
 A more rigorous kinetic analysis is to fit the stopped-flow data globally. In this 
analysis, we import a titration set (Figure 22) like with the analytical method but fit all the 
curves to a kinetic model simultaneously. The simplest model is: 
P + L                 PL, 
where (P) is the PTEN concentration, (L) is the surface lipid concentration, and (PL) is 
the PTEN-lipid complex concentration. The output signal is defined by the FRET signal 
that occurs during binding: 
Output signal = a*PL, 
where (a), is a multiplier for the output signal. This simple model accounts for the data 
when PTEN is mixed with single anionic component lipid vesicles composed of either PS 
or PI.  
The model for PTEN binding to vesicles containing PI(4,5)P2 need two steps to 
account for the data (Figure 23 a,b). The model to define these data is: 
P + L                   PL                bPL, 
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where the additional step is (bPL) bound PTEN-Lipid, signifying a strongly bound 
protein-vesicle complex. The signal output also has an additional value: 
Output signal = (a* PL + b*bPL), 
As shown in Figure 23b, this additional step fully accounts for the titration series. The 
results of these fits have been compiled in Figure 24.  
 The first conclusion that can be drawn from the data presented in Figure 24 is that 
the rate-limiting step is the first step. Interestingly, this step shows remarkably similar 
values for all vesicle systems (0.2 – 0.3 μM-1s-1), except the 10% anionic lipid/ 1% 
PI(4,5)P2.  The kon1 values are largely the same as the kon values found for the total lipid 
analytical approach. There is no dependence on the surface potential above ~14%, 
counting total valance contribution from the lipids. The koff1 also follows the same trends 
as found using the analytical method. What the global fit revealed, is the second step not  
Figure 22. An example of a single component fit. This data set is fully accounted for by the model P 
+ L = PL. The data is fit simultaneously to the model to derive the rate constants. 
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a 
b 
Figure 23. An example of a two-component fit of the stopped-flow spectrophotometric data. This 
data set is fully accounted for by the model P + L = PL= bPL. (a) The top figure shows the result when 
this data set is forced to a single component fit. Clearly, the model cannot account for the experimental 
data. (b) This graph has the additional step added to the model. All curves fit nicely into the model 
indicating that this reaction has a least to two steps.   
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found using the analytical analysis. This second step occurs only when PI(4,5)P2 is 
present in the vesicle system. 
 The second step results in a stronger PTEN-vesicle complex. The rates 
determined for kon2 show a fast transition; nearly 10-fold faster than the initial interaction 
characterized by kon1. This interaction is also strengthened by a slower and thus more 
stable koff2. The decrease in the koff is a little less than 10-fold as well.  
Figure 25 compares the global fits in terms of their Kd values. The Kd values were 
calculated for  each step as well as for the overall process i.e. koff2/kon1. The Kdoverall nicely 
follows the data as determined by the analytical method as well as previously reported 
results in the lab. The one exception is the 5% PI(4,5)P2 data. In this data set Kdoverall 
shows a very strong interaction where the analytical fit and previously reported 
Figure 24. The compilation of all the global fit rates by step of PTEN mixed with 
multicomponent model vesicles. Inset is the kon1 expanded. When PI(4,5)P2 is present the model 
goes from a one-step to a two-step description. 
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thermodynamically determined Kd shows weaker binding. There is a better comparison 
between the Kd1 of the global fit and the other 5% PI(4,5)P2 data.  
2.4 Discussion of Ensemble Kinetics 
  “Coincidence detection” is a common hypothesis seen in the peripheral binding of 
plasma membrane proteins. The idea is that proteins use multimodal binding domains, 
each of which interacts with a unique lipid substrate. In the plasma membrane, these 
lipids are usually PI(4,5)P2 and PS.  Examples of enzymes that leverage this process are 
PKCα, myotubularin, and PTEN 7. PTEN coordinates two distinct lipid sites which are the 
PBD and the C2 domain. We sought to push this hypothesis one step furtherby 
hypothesizing that there may be enhanced binding when the lipid substrates are clustered 
into domains. There is evidence in previous work that the anionic lipid PI can cluster 
Figure 25. The Kds calculated for each reaction step. Kd1 is koff1/kon1, Kd2 is koff2/kon2, and Kdoverall is 
koff2/kon1. The Kdoverall from the global fit follows that KdTotalLipid of the analytical data set, except for 5% 
PI(4,5)P2. With this system, the Kd1 from the global fit matches the analytical data better. 
. 
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PI(4,5)P2. It is a tempting thought that PI, rather than PS acts as the partner lipid in PTEN 
binding. It has a (-1) valence charge like PS but also has an additional characteristic that 
it is the precursor to all phosphoinositides.  Also, a cluster of the monovalent lipid with 
PI(4,5)P2 could form a potential well and drive the protein to the membrane. The results 
of these experiments have shown quite unequivocally that this is not the case.  
 The first hurdle we had to overcome was how to conduct the data analysis. It is 
apparent from the experiments that the rates are affected by the concentration of the 
substrates. The result means that the reaction is at least second order. The question with 
mixed lipid vesicles is how to define the concentration, since they will affect the 
association rate. The most obvious method is to use the concentration of the vesicles. 
Our vesicles are monodispersed, so the vesicle number and the lipids making them up 
are proportional. Our first brush at the calculation is to use the total surface lipid 
concentration. Using this method, we are testing the effects of the vesicle type on PTEN 
vesicle binding. The other option is to exclude the neutral lipid component which is known 
not to contribute to the binding; we dub this total anionic lipid concentration. Next, we can 
account for the valence of the anionic lipids. PI and PS have a valence of (-1) and 
PI(4,5)P2 (-4). This is a necessary analysis to consider since the increased potency of 
PI(4,5)P2  could merely be from being a more potent electrostatic contributor rather than 
a unique stronger interaction such as hydrogen bonding. Finally, we can account for the 
mol% of the “target” lipid. For the single anionic lipid component vesicles, this is rather 
simple. With the dual anionic vesicles, there is a large assumption that PI(4,5)P2 is such 
a stronger binder that it is only useful to consider the phosphoinositide contribution. All of 
these methods of analysis allow for unique insights, though by far the fairest test is the 
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total surface lipid. The drawback is that it likely greatly underestimates the “true” rate of 
association. After careful analysis using all of these methods for the analytical section, 
we thought it prudent to limit the global fit to the total surface lipid contribution.  
This careful analysis at first revealed how little the surface potential effects the rate 
of binding. Above a total valence charge of (-14), the rates saturate. Even at the highest 
possible potential of 98% anionic lipid the value is within the statistical limits of 30% 
anionic lipid. If there is no difference in the association between these two experiments, 
it is not surprising that there is no effect when there is a  nano-sized domain of binding 
lipids. Speculation what causes this phenomenon can be explored through the Gouy-
Champman-Stern theory56-58.  
 Gouy-Chapman-Stern theory predicts that when the surface potential, ψ(0), is 
small, it is related to the surface charge density, σ, and the Debye length, κ-1: 
ψ(0) =
𝜎
𝜀a𝜀0𝜅
 ,                                                         Eq 4. 
moreover, the potential varies with distance from the charged surface: 
ψ(x) = ψ(0)𝑒−𝜅𝑥                            Eq 5. 
Qualitatively, this theory states the charged surface will attract counterions, repeal co-
ions and produce an anionic environment within the charged surface’s proximity56-58. 
Importantly we are working in an electrolyte solution, 150mM. This decreases the 
potential from the fixed charges on the surface, i.e., negatively charged lipids, and the 
protein. This translates to a change in Debye length. It has been calculated that in the 
absence of an electrolyte the magnitude of the potential is 25mV at 1.5 nm from the 
surface. This decreases to 0.7nm in 100 mM of monovalent salt56-58.  
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 Another unusual quality of charged surfaces is that changes in salt concentration 
in the bulk solution does not affect the concentration of ions in the double layer. Increasing 
the salt concentration only contracts the Debye length of the double layer. This has a two-
fold effect on our system if we force it to this simple model. (1) There is an upper limit to 
how many charged PTEN molecules can accumulate in the double layer before the initial 
interaction. This results in a protein crowding effect. (2) As PTEN binds, it slowly 
neutralizes the vesicle decreasing the surface potential as PTEN moves from the 
aqueous layer and becomes a part of the charged surface. This effectively increases the 
Debye length during the reaction making a larger capacitive gap in which the enzyme has 
to jump to interact with the surface. (3) There may be a maximum anionic lipid composition 
for a given salt concentration where a closer Debye length gives no additive benefit. In a 
simple example with and without an electrolyte, the Debye length decreases by an 
estimated 0.3 nm. The electrostatics of our systems are more complicated than the theory 
above, we have multivalent lipids in some of our vesicle mixtures, and PTEN is clearly 
not a point charge. Nevertheless, even in the simplest models, the changes in potential 
as an effect of surface charge decreases as the surface charge increases in 100mM salt. 
All of this together supports our results where after a certain surface concentration of 
charge is reached, the benefits of increasing the charge further decreases as a route to 
drive the protein to the membrane.  
The second major result from these data is the special role that PI(4,5)P2 plays in 
PTEN-vesicle interaction. It has been well established that PI(4,5)P2 is necessary for the 
activation of PTEN to turn over PI(3,4,5)P3. Later it was found that when PTEN binds to 
PI(4,5)P2 a conformational change is triggered 8, 11, 36. When the studies first began we 
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thought we might be able to see this conformation change in the tryptophan fluorescence. 
When binding there is a shift of the emission peak to longer wavelengths, 320nm → 
335nm. Unfortunately, the system is too noisy to distinguish if there is a change in the 
kinetic experiments from the raw data alone. When fitting each curve individually in the 
analytical method, they fit very well to eq2. Therefore, we concluded that we could not 
follow the conformation change.  
Global fitting was necessary to find this nuanced difference. When trying to fit all 
the substrate concentration dependent curves simultaneously, it became immediately 
apparent that the kinetics where more complex than the simple model could account for. 
This increased complexity manifested itself only in the PI(4,5)P2 containing vesicle 
systems. There are two possible explanations for the second rate constant we observe in 
the PI(4,5)P2 containing vesicles: First, we may be able to observe the conformational 
change of the protein, leading to a change of the Trp emission maximum due to the 
changed environment and hence an altered FRET transfer efficiency. A second possible 
explanation for this second rate constant is that the protein binds initially weakly 
electrostatically which is followed by the binding to PI(4,5)P2.  
 The comparison between the analytical methods and the global fit methods gives 
us confidence in our results. For all the data, except 5% PI(4,5)P2, the trends of the Kdoverall 
and KdTotal Lipid agree with each other. 5% PI(4,5)P2 in the global fit work shows a stronger 
binding constant, yet Kd1 is comparable to KdTotal Lipid. Previously in this lab, reported 
thermodynamic Kd values also show a larger value than the kinetics (Table 3), 
highlighting the difference between the experiments. Nevertheless, the observed binding 
trends strongly support each other. This may indicate that thermodynamically, most of the 
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PTEN population when interacting with a 5% PI(4,5)P2 containing vesicle, may do so 
electrostatically and only a small portion makes a successful second step to the more 
strongly bound complex.  
 These results highlight how important it is for this bimodal protein to have access 
to both the phosphoinositide and the monovalent lipids. It is the stability of the complex 
that drives this interaction, which is determined both by the electrostatic potential of the 
vesicle and the phosphoinositide triggered conformational change of the protein. 
 This leaves us with some interesting questions. How does such a weak first step 
in binding effectively compete with all the activity at the membrane surface? Once the 
protein is bound is there then an effect on its lipid surface search algorithm whether there 
are clustered lipids are not? What does this mean for other peripheral, plasma membrane, 
surface binding proteins? For example, myotubularin is also a 3-phosphoinositide 
phosphatase which dephosphorylates PI(3,5)P2 to make PI(5)P and triggers the formation 
of an activated myotubularin complex11. Does this phosphatase “dance” along the 
membrane similarly to what we observe for PTEN? 
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Chapter 3: Single Molecule Study of PTEN lipid interaction 
 After establishing that PTEN’s membrane interaction is determined more by the 
stability of binding than by the association step, it is natural to investigate the dynamics 
of the lipid bilayer bound protein. In the stated hypothesis above, PTEN uses its 
multiple lipid binding domains synergistically to interact with lipid membranes and 
efficiently localize to its substrate. In this part of the project, individual molecules of 
PTEN interacting with solid supported lipid bilayers (SLBs) are tracked to determine how 
the different PTEN domains interact with model membranes of various compositions. The 
protein purification and the TIRF data were acquired by Rakesh Harischandra. I adopted 
the project after he completed his time in the group and used the developed Mathematica 
program to filter and analyze the data. The data analysis was based on a program that 
Dr. Jeff Knight at the College of Liberal Arts and Sciences at the University of Colorado 
Denver developed a few years back59, 60. We wrote this program based off an exemplary 
code from Knight and designed it for our work, and its method is outlined below.  Single-
molecule total internal reflectance fluorescence (smTIRF) microscopy was used to 
determine the diffusion constants and dwell times of PTEN constructs and compared to 
the behavior of the wild-type protein. The desired outcome is an understanding of how 
each part of the protein works together to result in a synergistic PTEN/lipid interaction.  
 Single-molecule tracking of biological events results in data without the time and 
population averaging.61, 62 This allows for the investigation of the stochastic behavior of 
individual enzymes in the system, unveiling a nuanced picture which with more traditional 
methods would have been averaged out.  The reality of cellular systems is that at the 
scale of the biochemical reaction the phenomena are stochastic. A recent paper has 
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estimated in yeast systems the total abundance of proteins to be between 1,000 – 10,000 
molecules.63 This is precisely the level of particles examined in smTIRF microscopy 
experiments. In this section, two types of single molecule analyses are reported, the 
diffusion of PTEN on model membranes and the single-molecule dissociation rates of the 
protein.  
 Diffusion constants will inform us how many lipids the protein and its domains 
strongly interact with. Knight et al59 have found that the diffusion of peripheral membrane 
proteins is a function of the number lipids the protein is bound to. The dwell time of the 
protein on the SLB are the inverse of the dissociation constant. A comparison of these 
data to the stopped-flow experiments described above is an independent method to check 
on our ensemble data. With the combination of ensemble data and the single molecule 
data, we hope to present a descriptive picture of how PTEN interacts with biomembranes. 
3.1 Methodology  
Supported Lipid Bilayers. 
 For the single-molecule experiments, the supported lipid bilayers were developed 
as follows. SUVs in a 50 mM KCl, 20 mM Citrate buffer (pH 3.5) were mixed with 1 M 
NaCl citrate buffer and flowed over the glass support. The glass support was prepared by 
first cleaning it in a piranha solution. These slides were then stored in HPLC water until 
ready for use. When needed the slide was dried with a stream of nitrogen and then 
cleaned with an oxygen plasma (2min). At this point, the slide is exposed to the SUV 
mixture and allowed to incubate for 30min. The slides were then washed with 20 mL of 
HPLC water followed by 20 mL of physiological buffer. To ensure that no bilayer defects 
are affecting the outcome of the single molecule experiments, holes in the lipid bilayer 
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were filled by flowing 100 μg/mL of BSA through the system8, 64. All of this work was done 
on a TIRF microscope slide in a gasket (CoverWell perfusion chamber) purchased from 
Molecular Probes (Eugene, OR, USA). The CoverWell perfusion chamber gasket was 
placed on the TIRF microscope slide immediately after plasma cleaning. They are 19 mm 
X 6mm X 0.5mm and proved to be an easy method to flush the membranes with various 
buffers and protein solutions as well as to keep the SLB hydrated. For a more thorough 
discussion on the current mechanism of SLB formation see in the methods section for the 
microfluidic experiment (next chapter).  
Sfp phosphopantetheinyl transferase method.  
To label PTEN and the domain constructs, we followed a protocol outlined by Yin, 
J. et. al.65. In brief, the method takes advantage of Sfp phosphopantetheinyl transferase 
to attach AlexaFlour probes to a short 11-residue peptide tag (ybbR). The ybbR tag has 
the peptide sequence DSLEFIASKLA which is fused to the C-terminal end of PTEN or its 
domains65. Sfp phosphopantetheinyl transferase covalently attaches 4’-
phosphopantetheinyl groups from CoA to the underlined serine of the ybbR sequence. 
The enzyme is tolerant of small molecules attached to CoA making it a convenient 
pathway to label proteins with small molecules.  
In this work, the fluorophore-CoA conjugates are synthesized by a one-step 
Michael reaction of the maleimide-functionalized AlexaFlour 647 (Thermo Fisher 
Scientific, Waltham, MA) and the free thiol group of CoA resulting in a thioether linkage 
between the two. To a solution of the AlexaFlour probe in 0.25 mL DMSO (starting 
concentration 5.6 mM) add 0.75 mL of CoA trilithium salt (starting concentration 2.8 mM) 
dissolved in buffer (buffer: sodium phosphate 100 mM, pH 7.0). The reaction mixture is 
68 
 
stirred in the dark at room temperature for an hour. To a total volume of a 100 μL of buffer 
(10 mM MgCl2, 50 mM Hepes pH 7.5) 0.1 μM Sfp, 5 μM AlexaFlour-CoA, and 5 μM of the 
ybbR construct are added (all final concentrations). The reaction mixture was allowed to 
incubate for 30min in the dark. The labeled protein was separated from the free dye by 
PD MiniTrap G-25 column (GE, Pittsburgh, PA) and the concentration was determined by 
measuring the absorbance at 647nm (CY5 option) using a NanoDrop spectrophotometer 
(ThermoFisher Scientific, Waltham, MA)64. 
TIRF Microscopy 
  Total internal reflection fluorescence (TIRF) microscopy is a technique which 
enhances the contrast of the images. This is achieved by angling the excitation laser so 
that the impinging beam has an incidence angle greater than the critical angle of the 
quartz slide. This results in total internal reflection within the coverslip and the formation 
of an evanescent wave which excites the fluorophores. The decay of the evanescent 
wave is rapid, meaning only a small depth of the sample is excited at one time (~100 nm). 
This reduces the number of fluorophores that are excited outside of the focal plane and 
thus results in a very high signal-to-noise ratio of the fluorescence signal8. Since TIRF 
microscopy only images labeled molecules close to the coverslip, it is particularly useful 
to probe molecules that reside at or near the plasma membrane (cells) or lipid bilayers 
(model systems).   
smTIRF microscopy is incredibly useful in single-molecule studies, especially 
when investigating processes at interfaces such as the plasma membrane of cells or on 
supported lipid bilayers. In these studies, protein and lipid dynamics are tracked both in 
time and space, and the behavior of individual particles are collected. In addition to the 
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kinetic information, these data can also impart structural information about the interface 
and how the protein manages complex membranes. This is realized in the cases where 
the movement of proteins at the interface deviate from Brownian motion. This can indicate 
obstructions or corralling of the protein as seen by a loss of linearity in the MSD-Time 
graphs used to determine diffusion constants.   
The fluorescence images were obtained with a Nikon (Minato, Tokyo, Japan) 
Eclipse Ti inverted microscope with a TIRF Illuminator. For excitation sources, coherent 
488 nm and 647 nm sapphire lasers were used. Images were captured with an Andor 
3iXon CCD camera (Belfast,UK). A Nikon 100 X CFI Apo TIRF oil objective with a 1.49 
numerical aperture was used for TIRF imaging. The 488 nm TIRF filter cube and Sedat 
Quad cube and Cy5 emission filter were purchased from Chroma (Foothill Ranch, Ca). 
Fiji and Mathematica Data Analysis 
 We use Fiji66 to do the initial image processing. For particle tracking, we took 
advantage of the plugin Mosaic.67, 68 Here we define three criteria for particle tracking; 
particle pixel radius (4 pixels), intensity percentage (20%) and nonparticle discrimination 
score (NpScore) (0). The pixel radius of 4 was chosen since it is just big enough to 
encopass the 2D Guassian profile of the particle (Figure 26). Too small, false detections 
are included in the particle selection, too big then the circumferences overlap. This 
overlap becomes an issue in the particle linking stage as the program builds the tracks. 
The program may mistake two particles for one, artificially shortening the trajectories. For 
these reasons, and with careful inspection a radius of 4 was chosen. 
Next, the expected brightness for the particles were selected. This spanned the 
upper 5%-20% of the intensity range of the image. This, like the radius was determined 
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by careful manual inspection to ensure white noise was not included in the selection as 
well as good particles not being missed. Finally, the NpScore was set to 0. This parameter 
is a cut off filter. By setting the value to 0 we included all NpScores in the data set. The 
NpScore system, determines the likeliness of a detection being a particle. It is used later 
in the Mathematica analysis.  
 After particle selection, we defined the parameters for particle linking to create the 
trajectories. The first parameter is how many frames should the algorithm link through if 
the particle blinks off. This was set to 2. The second is how far the particle can move in 
Radius = 3 Radius = 4 Radius = 5
Figure 26. Selection of the radius in the Mosiac plugin is an important step in determining real 
particles from spurious detections. A radius of 3 is too small and many false positives are included (white 
arrows). The radius 5 is too big, the red circumferences are starting to overlap for two neighboring particles. 
They are in danger of being encompassed by a single selection. A radius of 4 is just big enough to outline 
the 2D Gaussian profile of the particles.  
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two succeeding frames, this was set to 5 pixels. With a 100X objective 5 pixels cover 0.8 
μm. A high diffusion coefficent for a lipid is 4 μm2/s or 0.49 μm in 60 ms. We purposely 
overestimate the distance traveled because PTEN is a weak binder. It is likely that the 
protein can micro-dissociate from the membrane and re-bind quickly. To account for this 
phenomenom we used an increased area for which the particle could move and validated 
it with manual inspection after linking. This method as described above was set to 
intentionally oversample. Strict filtering rules are applied to the data in a program 
developed in the Mathematica software before the final analysis.  
 In the Mathematica program, we run the data through a series of exclusion tests. 
The first test filters tracks by the non-particle discrimination score (NpScore) (Figure 27). 
It is a value given to each particle through the mosaic software which determines “true” 
particles from spurious detections69. In the Mathematica program, we find the track 
NpScore by finding the mean NpScore of all the particle steps in each track. This track   
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Figure 27. The distribution of of the track NpScore plotted against frames. The track NpScore is 
calculated by finding the mean NpScore of the steps within a track. By plotting against the frame 
number, we can tell how long the track exists for a given track NpScore. This graph illustrates that a 
NpScore above 0.04 does not last for many frames, and likely to be made up of many “bad” particle 
selections.  
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NpScore is plotted for each track and plotted as a distribution. A filter is set at the min and 
max of this distribution to bracket around the trajectories that we want to keep. These 
data are then further filtered to exclude any tracks shorter than three frames (this will 
change with the exposure time, which ranges between 30ms – 50ms).  
The next filter is designed to exclude spurious detections (dim, short 
measurements) and contaminates (bright, long-lasting particles) by plotting the averaged 
particle intensity of a track against time (frames) (Figure 28). The filter is set to exclude 
these tracks. In the example below the filter is set to 3.5 and 9 to accomplish this. Despite 
this filter there are still an unacceptable number of immobile particles among the longer 
trajectories. To exclude these a final diffusion filter is applied.   
 
Figure 28. The intensity filter plots the mean intensity of the trajectory against how many frames 
the tracked particle exists for. The result is the short, dim tracks cluster to the left of the graph while 
long, bright particles cluster to the right. The short, dim particles arise from spurious detections and 
should be excluded from the data analysis. There are also some trajectories on the left in this example 
that exist for a long time. This is due to particles being on the perimeter of the image, on the edge of 
the 2D guassian excitation beam. Being close to the perimeter and outside of the center of the excitation 
source also mean that these tracks are poor canidates for particle tracking. The long, bright particles 
arise from aggregates and should be excluded as well.  
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Figure 29. The diffusion filter is the final exclusion test placed upon the data set. The diffusion is 
calculated for each tack and plotted against the number of frames with which the trajectory exists for. 
Immobile particles are found on the left side of the distribution. They swing up, composed of slow 
diffusions that exists for many frames (grey box). In addition, there are several fast diffusions that 
escape the earler exlusion tests (right side of the graph). These are also elimated from the data set. 
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The diffusion filter plots the diffusion against the number of frames the track exists 
for (Figure 29). It is mainly to exclude immobile particles, which are clustered on the left 
side of the plot (approximately < 0.03 μm2/s). In addition, there are a several tracks on 
the right of the distribution that are too fast. The selection for the fast diffusion is made 
when the right tail of the distribution drops below five frames. The remaining data is used 
to determine the diffusion coefficients and dwell times. Each data set had to have a least 
1000 trajectories pass the various filtering modes before being used. This was achieved 
by compiling multiple movies taken on a single experimental day (5-8 movies for one trial). 
All error bars in the data presented are from three independent experiments, (i.e., different 
days, independent protein and SLB preparations).       
Dwell Time Filtering and Analysis 
The dwell times for the PTEN interaction with different membranes were collected, 
and their cumulative distribution examined. By plotting the cumulative distribution the 
effects of binning errors are reduced since the cumulative result is independent of the bin 
size. In addition, the cumulative distribution is also useful for estimating the number of 
rate constants. The y-axis is the sum of all the events that has a dwell-time between zero 
and the associated time. Normalized, the cumulative distribution gives the probability that 
a dwell time falls below a given value.  
The dwell time binning starts after the first three frames of the movie. The bin width 
is set to be 3X the exposure time (i.e., if the exposure time is 30 ms the bins are at 90ms 
intervals) and accumulated out to 5 seconds. We chose to plot the dwell times as a 
fraction of the total cumulative dwell time population. To ensure that the dwell times are 
not artificially shorted, the data was passed through a few filters. The first is that any track 
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that starts on the first frame or ends on the last is removed. Also, if a track comes within 
6 pixels of the image perimeter, it is also excluded from the dataset.   
3.2 Diffusion of PTEN on SLB 
  To continue the exploration of the dynamics of PTEN on model membranes we 
tracked single PTEN molecules on the various SLBs using smTIRF microscopy. Figure 
30 shows a snapshot from a movie of wtPTEN on a SLB composed of 3%PI(4,5)P2, 
30%DOPS, 67%DOPC and 10ppb Rhodamine-PE. Before acquiring the movies (Figure 
30), the frame area was subjected to a high-intensity laser excitation to bleach any 
aggregates or fluorescent contamination. The laser was turned off, and the SLB was 
allowed to recover for three minutes. After this rest period, the movies were acquired for 
data analysis. Particles were selected and linked using the Mosaic plugin in Fiji as 
described in the methods section. The acquired trajectories were filtered and analyzed in 
Figure 30. Particle tracking of wtPTEN interacting with PI(4,5)P2/DOPS/DOPC solid supported 
lipid bilayers. (A) Particles are determined in the mosaic plugin by criteria selected by the user. These 
are the radius of the particle, its intensity and non-particle discrimination score (B) The tracked particles 
after 6.6s. To make the trajectories, the particles are linked between subsequent frames. This is 
determined by searching for the nearest neighbor within a defined distance. In this work, it was five 
pixels.   
 
(A) (B) 
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the Mathematica program. Using the filtered data, the diffusion coefficients of the protein 
and the PTEN domain constructs were determined by a two-step process.  First, to 
determine the mean squared displacement (MSD), the probability of finding the protein is 
plotted against increasing step sizes (Figure 31). This is done for each time interval for a 
total of 10 intervals. A time interval is dependent on the exposure length, so in the case 
of a 30 ms exposure, the time interval step would be 30 ms, 60 ms, 90 ms, etc. Figure 31 
illustrates one of these population distribution curves plotted against the step size for the 
90 ms time interval. It plots the percentage of PTEN that travels the distance r2 (μm) in 90 
ms. This population data is divided between 100 bins and plotted on a log scale. By 
plotting the data on a log scale, we can test whether the dependence is single or multi-
expotential60, 64 70. Having a multi-exponential fit indicates that there are multiple 
populations of molecules on the surface. The PTEN population data fit to the double  
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Figure 31. The PTEN population as a function of displacement after 90ms. The data is fit to equation 
7. The MSD of the fit are collected. This data fitting is repeated for at least ten time points.   
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exponential function with the form59, 60, 64, 70: 
1 − 𝑃(𝑟2) = 𝐴𝑒
−𝑥
𝑀𝑆𝐷1⁄ + (1 − 𝐴)𝑒
−𝑥
𝑀𝑆𝐷2⁄             Eq.6 
where (A) is the population of tracks with the resulting mean square displacement (MSD). 
(MSD1) and (MSD2) are the mean squared displacements for population 1 and 
population 2 respctively. The MSD of the protein is determined for at least ten frames 
(time intervals).  
This collection of data is used in step two. In step two, the MSD data is plotted 
against the time interval it was gathered at to build velocity graphs (Figure 32). The data 
fitting to two exponentials indicates at least two PTEN populations are existing on the 
SLB. In Figure 32 the respective populations are split into a fast diffusion and a slow 
diffusion group. The linear fit to determine the diffusion coefficient is59, 60, 64, 70:  
𝑟2 = 4𝐷𝑡 + 𝐶                               Eq. 7  
where (D) is the diffusion coefficient, and (c) is a constant. Whether the data fits to line or 
not, is informative. If the results are non-linear it can indicate anomalous diffusion either 
from corralling of the protein or directed diffusion (vesicles moving along cellular 
structures). Within the time range we looked, the data were linear, meaning they moved 
with Brownian motion, or simple diffusion.  
Figure 33 illustrates the difference between the two populations from Figure 32. 
The graph shows how far the respective populations of PTEN traveled in one second on 
the PI(4,5)P2/PS/PC SLBs. It the fast diffusion shows a protein that is able to explore 
them membrane environment. The slow diffusion sample shows a protein that is 
dedicated  
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single molecule diffusion data resulted in two groups, both of which can be fit to equation 8.  
 
Figure 33. Example tracks determined from the diffusion coefficients from the previous figure. 
These normalized tracks show the displacement of the fast PTEN vs. the slow PTEN after one second.  
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to a particular membrane region. We wanted to explore in this section, how the behavior 
of PTEN on different SLBs change. In addition, we followed the diffusion of PTEN 
constructs on these model membranes too. We wanted to see, if we could define which 
domains were responsible for strong interactions with the membrane vs. weak. The 
protein constructs tested were delPTEN (PTEN16-403, i.e., without the PBD domain) and 
the PTEN C2 domain (PTEN186-362). The resulting diffusion constants and populations 
making them up have been collected and presented below. 
Figure 34 shows the diffusion coeffcients of wtPTEN on 30% PS/ 3% PI(4,5)P2/ 
67% PC, 3% PI(4,5)P2/ 97% PC, and 30% PS/ 70% PC bilayers. The diffusion coefficient 
of the lipids was found to be 2.40 μm2/s (90% of the total lipid population) which is what 
was expected for a fluid lipid bilayer59, 60, 64, 70.  As stated previously, there are two PTEN 
diffusion populations. When tracking wtPTEN on membranes the major PTEN population 
has equivalent diffusion coefficients at ~1.0 μm2/s. The effect of different membrane 
compositions on PTEN dynamics becomes apparent when examining the slower (minor 
population) component. As expected, the diffusion coefficient increases from the 0.13 
μm2/s with PI(4,5)P2/PS membranes to 0.50 μm2/s with PS only membranes.  
Figure 35 shows the population split of these diffusion coefficients on these 
membranes. The population data shows that there is a larger population with a fast 
diffusion with the PI(4,5)P2/PS membrane when compared to the other two. The PI(4,5)P2  
and the PS membranes have approximately a 60/40 distribution of fast to slow proteins 
whereas PI(4,5)P2/PS has a 75/25 ratio. This result was unexpected. For wtPTEN on 
PI(4,5)P2/PS SLB we expected a 3 component fit. MSDs for PI(4,5)P2, PS, and 
PI(4,5)P2/PS. Instead, the data fit to a double exponential. Given that the fast diffusion  
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Figure 35. The population of wtPTEN on various model membranes determined by the analysis 
described above.  A large majority of the lipids fall into fast diffusion category and is basically a single 
population. PTEN has two defined populations.   
 
Figure 34. Diffusion coefficients of wtPTEN on various model membranes determined by the 
analysis described above. There are major, and minor components and the population distribution is 
outlined below. 
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has such a high population, we hypothesized that wtPTEN-PI(4,5)P2 and wtPTEN-PS 
both contribute to it, where the slow diffusion is wtPTEN-PI(4,5)P2/PS.  
Figure 36 and Figure 37 shows a PTEN construct with the PBD domain deleted. 
The PBD domain has been shown to bind to PI(4,5)P2 with high specificity. This 
interaction is necessary for the proper localization of PTEN on plasma membranes and 
results in a conformational change of PTEN36. The expectation with this construct is that 
it will make a weaker interaction with the membrane resulting in a faster diffusion 
coefficient. The fast diffusion rate of delPTEN on the PI(4,5)P2/PS and PI(4,5)P2 is the 
same as for the wtPTEN. While the fast diffusion rate of delPTEN on PS bilayers 
increased in comparison to wtPTEN. Interestingly, the slow diffusion component remains 
the same for delPTEN on 30% PS/ 70% PC SLBs. In contrast, the slow component of the 
delPTEN on PI(4,5)P2/PS membrane is increased by 6-fold. The slow component of 
delPTEN with the PI(4,5)P2 membrane also has the same diffusion coefficient as the 
Figure 36. Diffusion of the delPTEN (PBD deleted) construct of various lipid membranes. The fast 
component of delPTEN 30%PS shows a faster diffusion when compared to wtPTEN. Also, the slow 
component of 3%PI(4,5)P2/30%PS has an increased diffusion.   
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wtPTEN. What did change in the PI(4,5)P2 only system was the population distribution. It 
shifted from a 60/40 ratio to a 70/30 ratio towards the faster diffusion. Overall, the loss of 
the PBD domain either resulted in a faster diffusion or a redistribution of the populations 
to the faster component. 
The C2 domain of PTEN has been reported to interact in a Ca2+-independent 
manner with the lipid PS. The interaction, unlike the PBD domain, is nonspecific 
electrostatic meaning it should show a weak interaction with the membrane. The single 
molecule results in Figure 38 and 39 show that the C2 domain has the most dramatic 
difference when compared with wtPTEN experiments. The protein diffusion rate of the 
fast component for all the membrane systems increased. Also, over 80% of the C2 
domain population has shifted for PI(4,5)P2/PS to the fast diffusion component. The C2 
domain on PI(4,5)P2 membranes has an increased diffusion coefficient in comparison to 
wtPTEN for the fast component and maintains the shift towards the faster population with  
Figure 37. The population of delPTEN on various model membranes determined by the analysis 
described above.  delPTEN on 3% PI(4,5)P2 membranes distributed to the higher population when 
compared to wtPTEN data.    
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Figure 38. Diffusion of the PTEN C2 domain on various model membranes determined by the 
analysis described above.  All of the fast components display an increase diffusion. The slow 
component of the PS membrane also has an increased diffusion coefficient.   
 
Figure 39. The population of PTEN C2 domain on various model membranes determined by the 
analysis described above.  All three systems show a redistribution of the populations. 
3%PI(4,5)P2/30%PS and 3%PI(4,5)P2 shift to the faster diffusion, while the C2 domain on the 30%PS 
is more evenly split between the fast and slow.   
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75/25 fast/slow ratio. Finally, both the slow and fast diffusion coefficients for C2 domains 
on PS membranes have a faster diffusion. The difference between the populations 
decreased slightly but statistically, is still at a 60/40 ratio.  
 For proteins like PTEN, which bind to the plasma membrane via interactions with 
lipid headgroups, diffusion coefficients like these tell us how many lipids the protein is 
interacting with. The relationship, between diffusion and lipid interaction, was uncovered 
by the Falke group59, 60, 64. They engineered tandem PH domains and determined their 
diffusion coefficients. The PH domain that they used is well described and known to bind 
to a single phosphoinositide. By linking, two and three of these domains together with 
various sized linkers they uncovered this relationship. The diffusion for these types of 
peripheral binding peptides (like PTEN and PH domains) is dependent only on the lipids 
the peptide is interacting with, not the size or geometry of the protein. Figure 40 
summarizes lipid binding results for these PTEN constructs. Figure 40 highlights that the 
catalytic domain may be a major contributor in the membrane interaction. This is not 
usually discussed in the literature. It would be interesting to investigate if there is another 
specific interaction between PI(4,5)P2 and this domain. It would also be worthwhile in 
future work, to see if these data could be discriminated to fit with 3-exponentials, 
(especially for the 3% PI(4,5)P2/ 30%PS/ 67%PC). This may deconvolute the results and 
provide a better picture of what is occurring on these complex surfaces.   
3.3 Dwell Times 
In addition to the diffusion coefficients, dwell times can be calculated, and their 
cumulative distribution can be fit to derive a single-molecule koff (Figure 41). Like the 
diffusion data, population information can also be determined from these single-molecule 
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fits. The lipid data resulted in a single exponential decay while the protein data had a 
double exponential result. The cumulative data was normalized to the total dwells and fit 
to a double exponential with the form59, 60, 64, 71-73: 
1 −
𝐷𝑤𝑒𝑙𝑙N 
𝑇𝑜𝑡𝑎𝑙 𝐷𝑤𝑒𝑙𝑙𝑠
= 𝑃𝑒𝑇∗𝜏off1 + (1 − 𝑃)𝑒𝑇∗𝜏off2                 Eq 8.  
where (P) is the population associated with the toff and (toff1) and (toff2) are the rates of 
dissociation from the supported lipid bilayer. The inverse of these values are the dwell 
times associated with the protein or its domains on the selected model membranes. The 
lipid data is representative of the bleaching rate of the fluorophore. As expected it has a 
single exponential decay. For the protein, the contribution of photobleaching was explored 
Figure 40. This scematic summarized the diffusion results in terms of bound lipid. The colored 
lines (Black) and (Red) are representative of the major and minor populations, and are normalized by 
their length for easy comparison. The tida on the high lipid number is meant as an approximate count, 
since the relationship between diffusion and lipid number loses linearity after three lipids are bound. 
This scematic implicates the catalytic domain in the interaction. This particular domain in PTEN us 
usually over looked we PTEN membrane interactions are described.  
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at two different laser powers. For the AlexaFlour 647, it was found to be a negligible 
contributor to the rate data60.     
 Figure 42 shows the rates of wtPTEN on 3% PI(4,5)P2/ 30%PS, 3% PI(4,5)P2, and 
30%PS. The black column is the average of the two rate constants weighted by the 
particle population distribution from Figure 43. This average resulted in comparable 
values to the ensemble data obtained from the stopped-flow experiments (Figure 18). The 
averaged ensemble data for 30% PS and wtPTEN has a koff value of 7 +/- 0.7 s-1 and the 
single molecule data average is 8 s-1. The similarity of these results is remarkable. The 
3% PI(4,5)P2 and the multicomponent SLB, 3% PI(4,5)P2/ 30% PS, are difficult to 
compare since there is no direct comparison to the ensemble work (the PI(4,5)P2 percent 
composition is different between the two experiments).  
1 2 3 4 5
Time s
0.1
0.2
0.3
0.4
0.5
Number of Particles
Figure 41. Culmative distribution of dwell times of wtPTEN on 30%PS/3%PI(4,5)P2. The data is fit 
to equation 9 and also displays two populations like with the diffusion data. The exception is the lipid 
data which can be fit to a single exponential. 
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Figure 42. Rate constants of wtPTEN on SLB with the compositions 3% PI(4,5)P2/30% PS , 3% 
PI(4,5)P2,and 30%PS. The black column is the averaged rates weighted by the single molecule 
population. The red column is the major component, and the blue is the minor.   
 
Figure 43. The rate population of wtPTEN on SLB with the three stated lipid compositions. There 
was only one -component for the lipid only data and two for the PTEN data.    
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Table 4 shows the global fit results next to the single molecule koff. The rate trend 
for the multicomponent model membranes is 5%PI(4,5)P2/ 30% PS < 3% PI(4,5)P2 /30% 
PS < 1% PI(4,5)P2 /10% PS which is expected. The 3% PI(4,5)P2 single molecule 
dissociation rates are slightly slower than the ensemble 5% PI(4,5)P2 global fit results, 
which is unexpected considering the high PI(4,5)P2 concentration in the latter. For the 
fast component, there is a difference of a magnitude of 2 s-1 for the averages and 1 s-1 for 
the slow component. Even so, the koff values are very close considering the different 
methods used to investigate these systems. 
    What the single molecule experiments provide is a direct measurement of the 
population of PTEN enzymes for each dwell time component. The population distribution 
(Figure 44) of the dwell times for wtPTEN 3% PI(4,5)P2/ 30%PS membranes is 70/30 
(short/long dwell times). This result is also satisfyingly close to the diffusion rate 
Lipid 
Composition 
30% PS 3% PI(4,5)P2 5% PI(4,5)P2 
1% PI(4,5)P2 
10% PS 
3% PI(4,5)P2 
30% PS 
5% PI(4,5)P2 
30%PS 
Global Fit 1 
(s-1) 
7.7 +/-
0.2 
 7.8 +/- 0.8 37+/-5  2.7+/-0.6 
Global Fit2 
(s-1) 
  1.4+/-0.1 6+/-1  0.5+/-0.3 
Average 
Single 
Molecule 
(s-1) 
7.97 1.74   5.11  
Single 
Molecule 1 
(s-1) 
20 +/-1 5.8+/-0.7   14+/-4  
Single 
Molecule 2 
(s-1) 
4 +/- 1 0.4+/-0.1   1.9+/-0.7  
Table 4. A comparison of the global fit ensemble koff results with the single-molecule koff results. The 
average single molecule the mean of the two components from the single molecule data weighted by their 
population data.  
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population distribution (75/25). The 3%PI(4,5)P2 membranes are at a 60/40 ratio, and the  
30%PS membranes have a 75/25 distribution.    
  The delPTEN (Figure 44 and Figure 45) data shows the most dramatic difference 
in the short (fast) rate constant. In comparison to the wtPTEN data the 3% PI(4,5)P2/30% 
PS delPTEN fast component is 1.3 +/-0.3X faster, 3%PI(4,5)P2 is 2.6+/-0.8X faster and 
30%PS 1.1+/-0.2X faster. The slow component, on the other hand, shows small to no 
change. For wtPTEN on 3% PI(4,5)P2/ 30% PS the value is 1.9 +/- 0.7 s-1 while delPTEN 
is 1.4 +/- 0.2 s-1. For bilayers with 3% PI(4,5)P2, the dwell times are 0.4+/-0.1 s-1  and 0.84 
+/- 0.05 s-1 for wtPTEN and delPTEN, respectively and finally for 30% PS a koff of 4 +/- 1 
s-1 for wtPTEN and 1.7 +/-  0.6 s-1 for delPTEN is found. The population distribution of 
delPTEN has shifted in comparison to wtPTEN towards the higher population for 3% 
PI(4,5)P2 from 60/40 to 70/30. For the 30% PS data, the population shifted towards the 
longer dwell times from 70/30 to 60/40 for delPTEN. The multicomponent bilayer has the 
same population ratio between the short and long components when comparing wtPTEN 
and delPTEN. 
The C2 domain dissociation rates are not as intuitive as the previous results 
(Figure 46 and Figure 47). The koff for the C2 domain interacting with 3% PI(4,5)P2/ 30% 
PS has the same rate as the delPTEN within the error, 15 +/- 5 s-1 for the short rate 
constant and 1.5 +/- 0.2 s-1 for the long rate constant. For 3% PI(4,5)P2, the fast rate 
increased to 22+/-8 s-1 which is 1.3X time that of delPTEN and 3.6X faster than the 
wtPTEN dissociation rate. For bilayers with 30% PS, the C2 domain exhibits the same 
dissociation rate constant as delPTEN. The population data also trends to be 60/40 for 
3% PI(4,5)P2/ 30%PS, 65/35 3%PI(4,5)P2, and 30% PS 75/25.  
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Figure 44. Dissociation rate constants of delPTEN interacting with SLBs with the compositions 
3% PI(4,5)P2/30% PS , 3% PI(4,5)P2,and 30%PS. The black columns are the averaged rates weighted 
by the single molecule population. The red columns are the major component, and the blue is the minor.  
The delPTEN is a construct with the PBD domain deleted. 
 
Figure 45. The dissociation rate populations of delPTEN on SLBs with the three stated lipid 
compositions. There was only one -component for the lipid only data and two for the PTEN data.    
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Figure 46. Dissociation rate constants of PTEN’s C2 domain interacting with SLBs that have the 
compositions 3% PI(4,5)P2/30% PS , 3% PI(4,5)P2,and 30%PS. The black columns are the averaged 
rates weighted by the single molecule population. The red columns are the respective major component, 
and the blue is the minor.  The C2 is a construct that is thought to interact with lipid membranes with 
nonspecific electrostatics via the basic amino acids of the CRB3 loop and acidic lipids. 
 
Figure 47. The rate populations of PTEN’s C2 domain interacting with SLBs with the three 
stated lipid compositions. There was only one component for the lipid only data and two for the 
PTEN data.    
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 Taken all of the dissociation rates together it is surprising that there are not a more 
dramatic dissociation rate constant differences between the domain constructs. In fact, it 
is rather remarkable how consistent the data is between the different lipid compositions 
and the domains. The greatest change seen is between wtPTEN and delPTEN for the 
3% PI(4,5)P2/PC supported lipid bilayers.    
3.4 Discussion of Single-Molecule Results  
Single-molecule techniques allow for the investigation of biological systems at the 
actual scale of the biological system. This means gathering stochastic data from  complex 
biological systems but maintaining the heterogenic integrity of enzymes and uncovering 
new details of these processes not attainable with classic ensemble techniques62. In 
principle, a single-molecule experiment contains all the information of the molecular 
ensemble. This idea is derived from the statistical mechanic's ergodicity hypothesis. It 
states that the results over a sufficiently long time-average or a sufficient number of 
observations of single molecules would be equivalent to a standard population-average 
snapshot. In a review, N.G. Walter62 lists several advantages of the single-molecule 
experiment. (1) Reveals heterogeneity and disorder in a sample, (2) precise localization 
and counting of molecules in spatially distributed samples, (3) working at the low numbers 
observed for many biopolymers (typically 1-1000), (4) quantitative Markovian kinetics and 
statistics of biological systems, (5) uncover rare or transient species along a reaction 
pathway, (6) miniaturization and multiplexing of biological assay (i.e. single-molecule 
sequencing), (7) direct quanititative measurment of mechanical properties of single 
biopolymers and their assemblies, and (8) as Richard Feynman elegantly said, its also a 
way to “just look at the thing.”62 
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 The dwell time data average for the koff for wtPTEN on 3% PI(4,5)P2/ 30% PS, 3% 
PI(4,5)P2, and 30% PS SLBs, was comparable to the ensemble results. The 30% PS data 
from the single molecule and the stopped-flow techniques agrees with each other 
extraordinarily well. The 3% PI(4,5)P2/ 30% PS single molecule results also followed the 
trends of the stopped-flow data; 1% PI(4,5)P2/ 10% PS and 5% PI(4,5)P2/ 30% PS. The 
one outlier was with the single molecule 3% PI(4,5)P2 SLB when compared to the 
stopped-flow 5% PI(4,5)P2 system. The single molecule results showed a smaller 
dissociation constant than expected. Ultimately to check these results, experiments with 
lipid systems which have the same bilayer compositions needs to be explored. 
Nevertheless, within the range of our investigation the results recapitulate each other.  
Surprisingly, there is not as a dramatic change for the different domains when 
compared to wtPTEN on these SLB systems. The most significant change occurs on 3% 
PI(4,5)P2 SLBs when the PBD domain is removed. The small difference for the 3% 
PI(4,5)P2/ 30% PS bilayers between the two constructs is probably due to the 
overwhelming lipid component being PS. The loss of the PBD domain causes the enzyme 
to lose the ability sense the difference between the PI(4,5)P2 bilayers and the PS bilayers. 
The specificity for PI(4,5)P2 is associated with the PBD domain, and without it PTEN 
seems to interact only through non-specific electrostatic forces . 
 The comparison of the delPTEN and C2 domain gives insight into the contribution 
to PTEN binding between the catalytic domain and the C2 domain. The standout again is 
the 3% PI(4,5)P2 containing membranes. The C2 domain’s koff rate constant is even bigger 
than the one for delPTEN. For the other lipid mixtures though, the data for the C2 domain 
are not that different from the delPTEN data. This suggests that while there may be some 
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contribution to the binding from the catalytic domain, overwhelmingly the interaction via 
electrostatics is through the C2 domain. This is not surprising considering the basic amino 
acids of the CBR3 loop make a (+5) positive charge contribution. Also, these data drive 
home that PTEN’s specificity for PI(4,5)P2 is driven through the PBD domain. It also 
seems to be truly specific to the phosphoinositide as evidenced by the PTEN koff rates 
not changing with the PS membranes when tested with different domains.  
 The diffusion data support the rate data. There are two components, a fast 
diffusion, weakly bound component and a slower diffusing, stronger bound component. 
For wtPTEN the slow component trends as 3% PI(4,5)P2/ 30% PS < 3% PI(4,5)P2 < 30% 
PS as expected. Interestingly the fast component has the same diffusion coefficient for 
all three membranes. The delPTEN on 3% PI(4,5)P2/ 30% PS membrane has a diffusion 
and dwell time data with values like the 30% PS/ wtPTEN system. The PBD domain has 
a substantial influence on how many lipids the protein is interacting with. Falke and Knight 
et al. 60, 64 conducted a study where they attached tandem PH domains and investigated 
their diffusion coefficients. What they found was that diffusion is a measure of how many 
lipids are bound to the protein. This implies that the shift to a faster diffusion for delPTEN 
when compared to wtPTEN on the multicomponent membranes directly indicates that the 
protein is interacting with fewer lipids. The 3% PI(4,5)P2 may seem to be an outlier in this 
regard, but an examination of the population data shows a shift to the faster component 
as well.  
 The C2 domain diffusion data has a unique difference from the other two data sets. 
The main effect is that the fast diffusion component has increased in speed. Also, the 
population data for the PI(4,5)P2 containing membranes is shifted towards the faster 
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component while 30% PS became more evenly split. First, examining the 30% PS data 
indicates that the C2 domain has two interaction states with the membrane. The catalytic 
domain has some additional interaction with PI(4,5)P2, though weak as evidenced by the 
diffusion rate data. It is likely that the interaction occurs in the catalytic domain via the 
amino acids such as H93, which is known to hydrogen bind to the phosphate in the 5th 
position of the inositol ring. The real strength of the interaction occurs with the PBD 
domain. When this domain is deleted from the enzyme the benefit of binding to PI(4,5)P2 
is lost. The question of whether this increase of binding is due to the direct interaction of 
PI(4,5)P2 and the PBD domain or because the protein conformation changes causes the 
entire length on the protein to be a better binder cannot be answered currently.  Even so, 
the slow diffusion coefficient being so small does indicate that PTEN is interacting with 
many lipids on the surface, probably more than what 15 amino acids could account for. 
 Using both the ensemble data and single-molecule data we can suggest a detailed 
model for how the protein interacts with the membrane. The conclusions of these two 
projects are summarized in Figure 48. First, PTEN approaches the membrane. If the 
electrostatic potential is high enough, it will form a complex with the anionic lipids. It can 
either form a weakly bound fast diffusing complex, or if PI(4,5)P2 is present, can form a 
strongly bound complex. If it is weakly bound complex, the protein can quickly scoot 
across the surface until it finds PI(4,5)P2 and then form the strongly bound complex. Most 
of the protein is weakly bound, as shown by the single molecule work.  
 This weak interaction allows for a highly efficient search mechanism, only making 
a strong interaction if PI(4,5)P2 is present. The strong interaction with PI(4,5)P2 sacrifices 
lateral diffusion speed for the higher probability of finding the rare PI(3,4,5)P3. Even in a 
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scenario where there is only PI(3,4,5)P3 to start, PTEN would make PI(4,5)P2 causing the 
protein to having a longer residency time and ensure all the PI(3,4,5)P3 is turned over.   
  
C2 
Negative Potential 
C2 PD 
PD (+) (+) 
Weak Binding, Fast Diffusion 
Strong Binding, Slow Diffusion 
Lateral diffusion 
Figure 48. A model to account for the ensemble and single molecule results. First PTEN 
approaches the membrane due to the negative potential from the lipids. Second, depending on 
whether PI(4,5)P2 is present or not PTEN can either be a weakly bound and fast diffusing or strongly 
bound and slow diffusing. If it is weakly bound, PTEN can quickly scoot across the membrane until it 
finds PI(4,5)P2 and then become a strongly bound complex. The single-molecule data suggest that the 
majority, 60 to 70% of the membrane-associated PTEN is the weakly bound complex while only a minor 
portion of the population is strongly bound.  
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Chapter 4: Using Microfluidics to Generate a Gradient of PI(4,5)P2 in 
Supported Lipid Bilayers  
Many eukaryotic cells display distinct plasma membrane morphologies that 
depend on their life cycle. These morphologies are often dynamic, show a high level of 
complexity and in some instances give rise to polarized cells. We are interested in 
understanding how cells control micron scale polarization of membrane organization as 
seen during processes such as cytokinesis and chemotaxis or within statically polarized 
epithelial cells. PIPs and their interactions with proteins are pivotal for many of these 
dynamic and static membrane polarizations74, 75. 
A laterally non-uniform distribution of phosphoinositides is the hallmark of many 
important cellular events. In cytokinesis, for example, PI(4,5)P2 production and 
polarization are crucial for spindle orientation, mitotic cell shape and bridge stability after 
furrow ingression. Subsequently, PI(4,5)P2 hydrolysis is essential for normal cytokinesis 
abscission76-79. Chemotaxing cells, such as Dictyostelium discoideum or neutrophils, 
show distinct and dynamic phosphoinositide polarization characterized by the 
accumulation of PI 3-kinase and phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) at 
the leading edge of the migrating cell76-80. An example for polarized cells with a globally 
static polarized structure is absorptive epithelial cells. Epithelial cells increase their 
surface area by developing the so-called “brush border” membrane, which is a highly 
structured plasma membrane characterized by long, thin, highly curved structures 
(typically 100nm in diameter and 100nm - 2,000nm in length). The apical side of epithelial 
cells shows increased PI(4,5)P2 concentrations, while the basolateral side exhibits 
increased PI(3,4,5)P3 concentrations in the PM76, 77, 79, 81. 
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Phosphoinositides have been shown to bind a broad range of protein targets that 
are involved in an extraordinary array of physiological functions82 including those crucial 
to cell motility. Temporal and spatial control of phosphoinositide levels consequently 
regulates the phosphoinositide-binding protein functionalities. This spatiotemporal 
organization is an important aspect for the proper execution of these signaling events. 
While several studies have described polarized phosphoinositide distribution in living cells 
in response to external stimuli, many aspects of the generation and maintenance of such 
gradients, in particular concerning the physical chemistry of the underlying processes, 
have not been sufficiently detailed. Despite the obvious benefits of combining the results 
from in vivo and in vitro studies, there is, to the best of our knowledge, currently no in vitro 
platform available that provides the experimental freedom required to investigate the 
many biophysical facets of lateral membrane gradients. To understand the biophysical 
underpinnings of membrane gradients concerning mediating signaling events, it is 
important to have complete experimental freedom concerning the composition and 
physical properties of the lipid bilayer as well as the nature of the chemical species (e.g., 
proteins, bivalent cations) interacting with that bilayer. It is the goal of this project, to 
develop a device that allows for the systematic investigation of how gradients can be 
created, how they are maintained and how proteins affect and interact with such lipid 
gradients76, 77, 79.  
 Solid-supported lipid bilayers have been established as facile tools for the 
biophysical characterization of model membrane systems82-86. The Sanii87 and Huskens88 
groups both utilized SLBs to develop biomimetic devices for the preparation of lipid 
membrane gradients. With the device developed by the Sanii87 group, a membrane 
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gradient can be created that enables the investigation of gradient diffusion, protein-lipid 
interactions, and gradient dependent domain formation. Their method uses a three-
dimensional PDMS stamp to deposit two spatially separated multilamellar lipid stacks 
onto a glass coverslip. Upon rehydration, the stacks “heal” the divide between them 
forming a contiguous unilamellar SLB with a gradient between the two deposited 
multilamellar lipid stacks87. 
 The Huskens88 group developed an experimental platform that can ‘lock-in” the 
desired lipid gradient profile in an array of micron-sized Cr corrals. In their work, they use 
a mixture of zwitterionic and negatively charged lipids with a high melting point to obtain 
the lipid bilayer. Heating the system to above the phase transition temperature causes 
the lipids to enter a mobile fluid phase, and a gradient of the negatively charged lipids 
within the lipid bilayer is obtained by applying a voltage that draws the charged lipids to 
one side of the corral. Upon cooling below the phase transition temperature of the lipid 
mixture, the lipids enter the gel phase, “locking-in” the gradient88. 
 The Sanii group’s experimental platform is simple and generally has no limitations 
concerning the composition and physical properties of the lipid stacks (e.g., lipid phase 
transition temperature and charge). However, the shape and slope of the lipid gradient 
cannot be controlled by this device. The method introduced by the Huskens group allows 
for a highly tunable lipid gradient; the length scale of the membrane gradient is in a 
physiologically relevant range, and the gradient can be “locked-in,” which is potentially a 
major advantage for sensor applications. However, the method requires lipids with high 
gel/liquid-crystalline phase transition temperatures and the use of an electric field to 
create a lipid gradient of anionic lipids. In both methods, the gradient formation is 
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restricted to the SBL, i.e., the fluid phase above the lipid bilayer cannot exhibit a gradient 
of one or more of its constituents (e.g., a non-uniform distribution of a lipid-modifying 
enzyme). 
 The device that we have developed combines the advantages of both existing 
techniques. These include the freedom of choice concerning the lipid composition and 
physiologically relevant length scales over which the gradient is generated. In addition to 
this, our device adds the ability to create a protein or bivalent cation gradient in the 
aqueous phase above the lipid bilayer. It is even possible to fabricate a gradient in the 
lipid bilayer with an opposing gradient in the aqueous phase. The steepness of the 
respective gradient and within certain limits its functional behavior can be chosen based 
on the experimental objectives. To show the broad applicability of this microfluidic device, 
we will demonstrate that we can create phosphoinositide gradients on various length 
scales, ranging from 2 mm to 50 μm. We further show how a gradient in the aqueous 
layer above a homogeneous lipid bilayer can impart a non-uniform response in the lipid 
bilayer. This biomimetic platform can be combined with a Total Internal Reflection 
Fluorescence (TIRF) microscopy setup, which allows for the convenient observation of 
the time evolution of the gradient and the interaction of ligands with the lipid bilayer. 
4.1 Methodology 
Constructing the Microfluidic Platform 
The Sylgard 184 silicon elastomer kit (Dow Corning, Midland, MI) was used to 
make the polydimethylsiloxane (PDMS) component of the microfluidic device. This piece 
of the device is where the channels are imprinted from a silicon master during the molding 
process. To do this, curing agent (10% by weight)  added to the elastomer base and then 
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mixed vigorously. This was then followed by degassing the mixture for an hour. The 
uncured PDMS was poured onto the silicon master, degassed for an additional 10 
minutes and then cured in the oven at 72°C for 45 minutes. The now hardened PDMS 
was cut from the silicon master, and the inlet and exit holes were punched with a blunt 19 
gauge BD PrecisionGlide needle. This PDMS mold, with the silicon master design 
imprinted on its surface, was further cleaned with Scotch tape to remove dust and debris. 
This is the top of the microfluidic device. 
 The base of the microfluidic device is a 24X40mm N0.1.5 Gold Seal cover glass 
slide used for TIRF microscopy. The TIRF slide was piranha cleaned for an hour, rinsed 
with copious amounts of HPLC water and stored in HPLC water until needed. The slide 
is then rinsed with methanol and dried under N2 gas. 
 At this point, the PDMS mold and TIRF slide are plasma cleaned with an air 
plasma. First, the TIRF slide is placed in the chamber and plasma cleaned for two 
minutes. Then the Scotch tape is removed from the PDMS, and the PDMS is added to 
the chamber. The PDMS and TIRF slide are cleaned for an additional 45 seconds. The 
slide is then placed over the PDMS mold and with gentle pressure sealed to the PDMS. 
This is an irreversible attachment. 
Developing a Supported Lipid Bilayer in the Microfluidic Platform 
To form SLBs loading buffer is passed through the microfluidic device from the 
outlet. By passing this solution in the reverse direction of the setup, we ensure that all air 
bubbles are pushed out of the device. Also, this priming allows us to check for leaks since 
the pressure from pushing the fluid by hand into the device is much higher than the 
pressure achieved by the syringe pump that will be used during the experiment. To 
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introduce any liquid from the inlet side into the microfluidic device, a 3mL syringe with a 
25-gauge needle is attached to the inlet using PTFE#3 AWG thin wall tubing from Cole-
Parmer. This tubing OD and the needle OD were matched to ensure a liquid-tight seal. In 
our observation, the only time leaking occurs is when there is back pressure due to a 
clog. 
The vesicle suspension can be introduced through the inlets. Here three syringes 
are attached to two feet of tubing. When making homogeneous SLBs, the three syringes 
are filled with vesicle suspensions of equal concentrations (1mM). When the syringe 
pump is run at 10μl/min and with two feet of tubing it takes twenty minutes for the vesicles 
to reach the observation chamber. This “dead-time” can be adjusted by either changing 
the length of the tubing or speed of the syringe pump. This method was used in our initial 
test experiments to follow SLB formation by fluorescence microscopy. 
 A more convenient method is to introduce the vesicle suspension through the 
outlet of the microfluidic device by using a hand-driven syringe. This is the procedure we 
used to obtain laterally homogeneous lipid bilayers once we had confidence in the SLB 
formation. After 100μl of the suspension is passed, the vesicle suspension is allowed to 
sit for 30 minutes in the observation chamber. Then 100μl of HPLC water is passed to 
break any remaining intact vesicles due to osmotic stress. This is followed by 100μl of the 
physiological buffer. While we were not able to discern any macroscopically visible 
imperfections in the lipid bilayer (e.g., holes), it cannot be ruled out that such imperfections 
exist below the resolution limit of the microscope. To fill in these potential holes, a 100μl 
of a BSA solution (5μg/mL) was introduced into the observation chamber and allowed to 
sit for 30mins. This is followed by a final wash with a 100μl of our physiological buffer 
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again. To maintain the integrity of the SLB, it is important that no air bubbles are moving 
through the device as these various solutions are introduced. 
Establishing a PI(4,5)P2 Gradient 
Insertion Method 
The critical micelle concentration (CMC) for TopFluorPI(4,5)P2 is not known, 
however, using dynamic light scattering measurements we have found for nanomolar 
concentrations that TopFluorPI(4,5)P2 is dissolved as a monomer. We take advantage of 
this property, by creating three TopFluorPI(4,5)P2 solutions of different concentrations 
below the CMC, which are then being used to generate a gradient of fluorescently labeled 
PI(4,5)P2 embedded in an otherwise homogeneous lipid bilayer. Aqueous 
TopFluorPI(4,5)P2 solutions with three different concentrations are obtained by drying 
appropriate amounts of the lipid from organic stock solutions as described above and 
redissolving the lipid film in the loading buffer. The aqueous samples are then drawn up 
into three 1mL syringes, and any air bubbles present in the syringe are removed. Then a 
25G needle with two feet of tubing is attached to the syringe. The syringe plunger is 
depressed so that the solution is pushed through to the end of the tubing. All three 
syringes are placed in the syringe pump, and the bar is placed against the plungers so 
that there is a small drop at the end of each tube. The tubes are inserted into the 
microfluidic inlets, and the syringe pump is started. The syringe pump is run for 20 minutes 
at 10μl/min. During this time the TopFluorPI(4,5)P2 partitions into the homogeneous SLB 
that has been previously made. To push any labeled lipid that did not insert into the lipid 
bilayer out of the observation chamber, the syringe pump is stopped, and the syringes 
with the lipid solutions are replaced with three new syringes that are loaded with 
physiological buffer solutions. The physiological buffer solution is run for 20 minutes at 
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the same rate as the lipid solution before. After this point, the syringe pump is stopped, 
and the fluorescence imaging of the bilayer starts. For these experiments, a 60X TIRF 
objective is rastered across the observation chamber perpendicular to fluid flow.  
 While the method described above is suitable for the microfluidic device with the 
large observation chamber because of the long equilibrium times for the gradient, a 
different method is needed for the microfluidic device with the sub-millimeter chambers 
(for the narrower chambers the equilibration occurs on a time scale of minutes rather than 
hours). To deposit the labeled PI(4,5)P2 and flush the SLB with buffer, the transition 
between these solutions needs to be immediate. To achieve this the labeled solution with 
the labeled PI(4,5)P2 is first pushed through the syringe to the end of the tubing before 
attaching it to the microfluidic system. The syringe is then switched with a buffer loaded 
syringe. This is then attached to the inlets of the platform. The result is that when the 
syringe pump is started labeled PI(4,5)P2 is introduced and immediately chased with 
buffer in a process we deem as a load (deposition of labeled PIP2) followed by flush (wash 
with buffer). The imaging is started when the syringe pump is started. With the load-flush 
experiment, the buffer is run for twenty minutes and then stopped with an image taken 
once every minute for an hour at the start of the syringe pump. 
Direct Deposition Method 
Gradients Beyond Lipids 
The SLB films were prepared as described before. Three membranes were tested 
for the interaction with a Ca2+ gradient: 5% PI(4,5)P2, 94.9% DOPC, 
0.1%TopFlour®PI(4,5)P2; 5% PI(4,5)P2, 30%Cholesterol, 64.9%DOPC, 
0.1%TopFluor®PI(4,5)P2; 30%POPS, 69.9%POPC, 0.1%TopFlour®PS. Physiological 
buffer solutions (see above) with 1mM, 2mM, and 3mM calcium concentrations were 
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prepared and loaded into the three syringes connected to the inlets of the microfluidic 
device. The Ca2+ buffer solutions were pumped through the microfluidic device with 
10μl/min rate while simultaneously obtaining TIRF images of the respective lipid bilayer. 
Images were taken every 5 minutes for an hour for the PI(4,5)P2 SLBs. For the PS-
containing membranes, the objective was rastered in a 2.0mm x 2.5mm rectangle once 
every 20min for 22hrs. The images at each time point were stitched together and 
analyzed. 
Imaging the Gradients 
The stitching of the rastered images to a single image was done using the Nikon 
Elements software. All other image processing was done in ImageJ (NIH Bethesda, MD). 
For the topology images, a movie at nine positions across the channel was acquired. The 
mean fluorescence intensity was calculated for each frame of the movie. These data were 
imported into Origin software (Northhampton, MA) and a topology graph of the mean 
fluorescence intensity was plotted against time and position. 
 For the Ca2+ experiments, the data was acquired by the same means as above. 
Instead of calculating the mean fluorescence intensity, the intensity was thresholded to 
the top 1.3% of intensity brightness. This was then converted into a binary image where 
the brightest areas are counted as domains by selecting the thresholded areas that have 
pixel diameter greater than 52 pixels and a circularity between 0.5 - 1. These domains 
were counted, the average diameter calculated, and percent area of the frame determined 
for each frame of each movie. These data were imported into the Origin software, and 
two topology graphs were constructed: number of domains as a function of time and 
position, and the percent area of the frame as a function of time and position67. 
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4.2 Insertion of aqueous PI(4,5)P2 in SLB 
The work of Byfield et. al.89 was the 
inspiration behind using a microfluidic 
gradient generator to make laterally 
heterogeneous supported lipid bilayers 
(SLB). The “Christmas tree” design of this 
microfluidic platform, originally fashioned 
by S. Dertinger et al., 90, 91 takes three 
different initial concentrations and forms a 
gradient in the observation chamber of the device. The lamellar flow of the fluid prevents 
mixing perpendicular to the flow direction once the fluid enters the observation chamber 
(Figure 49). At the first level of the mixing tree, there are three inlets that split and 
 
Figure 49. Wide-field fluorescence image of the 
microfluidic gradient generator with a 
homogenous SLB composed of DOPC and 
1%RhodaminePE. The three initial 
concentrations are introduced into the inlets. They 
are of equal concentrations and composition, 
resulting in no gradient. The high fluorophore 
percentage was used for aesthetic reasons to 
highlight the features of the microfluidic platform 
design. 
 
 
Figure 50. The setup of the microfluidic platform on the TIRF microscope. (A) Demonstration of 
the connection between the syringe pump and the microfluidic platform. The fluids in the syringe set 
varies in concentration and or composition to develop a gradient. The syringes are connected via 2ft of 
tubing to the microfluidic device, and the rate of flow is controlled by the syringe pump. (B) The tubing 
connections to the microfluidic platform as well as the outlet tubing which empties into a waste vial. The 
objective is centered over the observation chamber to record the changes of the SLB gradient. Since 
this setup is placed directly on the microscope, images can be acquired in real time at all stages of the 
experiment, which is critical for monitoring the gradient evolution under various conditions. 
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recombine the initial sample concentrations to form four new concentrations. This process 
is repeated at each subsequent level, ending in a total of nine outlets which recombine 
into the large observation chamber. When a concentration series is introduced into the 
microfluidic device, (see Figure 50 for the physical setup of the device and Figure 51 for 
images of a lipid sample gradient) the concentration gradient brackets the lowest and 
highest concentrations of the three samples introduced through the device inlets. The 
steepness of this gradient is highly tunable by controlling the flow rate of the fluid through 
the device, where at the highest speeds the gradient forms a step function91. The lamellar 
flow of the fluids as they exit the nine channels to enter the observation chamber is 
essential for successful gradient development. The lack of turbulent mixing perpendicular 
to the fluid’s flow direction means that the only physical pathway for the gradient to 
equilibrate is by the Brownian motion of the dissolved molecules or suspended vesicles. 
The lamellar flow of the fluid is a key physical characteristic of the device since it provides 
maximum flexibility concerning the kind of gradient that is being generated, being it 
dissolved molecules or suspended unilamellar vesicles92, 93 (Figure 51). 
4.3 Generation of a PI(4,5)P2 gradient in a DOPC SLB.  
  To generate a PI(4,5)P2 gradient, first, a homogenous SLB composed of DOPC 
and Rhodamine-PE (Rh-PE/10ppb) was created in the microfluidic device (Figure 51B). 
The Rh-PE is added to the SLB lipids to check for macroscopic defects and to check the 
bilayer’s fluidity using smTIRF (in our experiments we bleach a portion of the SLB and 
check for recovery in that area after 10 mins). To visualize the gradient of 
phosphoinositides, we utilized fluorescently labeled TopFluor-PI(4,5)P2 (10nM, 30nM, 
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60nM). We have found that the lipid is monomeric in aqueous solution at these 
concentrations. Due to the negative charge of the TopFlourPI(4,5)P2 headgroup and the 
steric hindrance imposed by the large fluorescent label on the acyl chains, the mutual 
interaction of these lipids is dominated by repulsive electrostatic forces, resulting in a 
critical micelle concentration (CMC) significantly higher than the nanomolar 
concentrations used in our experiment (please note that the CMC for unlabeled PI(4,5)P2 
is in the 30 – 40 M range) 94. A gradient of monomeric (dissolved) TopFlourPI(4,5)P2 
can, therefore, be obtained in the aqueous phase when these three different 
Figure 51. TopFluorPI(4,5)P
2
 gradient in a homogeneous DOPC bilayer labeled with Rhodamine 
PE. (A) Widefield fluorescence image of the microfluidic platform’s observation chamber showing a 
TopfluorPI(4,5)P2 gradient in the aqueous phase above the SLB. (B) Stitched fluorescence image of the 
homogeneous DOPC bilayer labeled with 10ppb Rh-PE. After the SLB was fully developed, the 
observation chamber was flushed with buffer solution to remove any remaining lipid vesicles. After the 
wash, the TopflourPI(4,5)P2 gradient with inlet concentrations of 10nM, 30nM, and 60nM was 
introduced. (C) Stitched TIRF image of the DOPC bilayer with inserted TopFluorPI(4,5)P2. The individual 
image squares are representative of one camera frame (single individual image before stitch, 138.24 
μm x 138.24 μm).  
  
1mm 1mm (A) (B) (C) 
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concentrations of the lipid are introduced into the three inlets of the microfluidic device 
(Figure 51). The partition coefficient between the aqueous solution and the SLB of the 
lipid still leans toward membrane incorporation, so, as the TopFluor-PI(4,5)P2 flows over 
the DOPC SLB, the labeled lipid will spontaneously insert. The lamellar flow of the 
microfluidic device ensures that there is no cross-channel mixing (Figure 51A), 
maintaining the aqueous PI(4,5)P2 gradient during the insertion process (Figure 51C).  
Figure 52 shows the results of TIRF imaging of the SLB after the insertion of the 
TopFluor®PI(4,5)P2. We acquired image 52A by rastering the 60X TIRF objective 
perpendicular to the fluid flow, taking an image at nine equally spaced positions. This 
scan was repeated once every 30min for 24 hours to monitor the time evolution of the 
PI(4,5)P2 gradient. As can be seen qualitatively, the TopFluor®PI(4,5)P2 gradient is 
maintained as the lipid inserts into the preformed SLB and slowly equilibrates over 24 hrs. 
Figure 52B shows the mean fluorescent intensity per image frame across the observation 
channel (i.e., perpendicular to the flow direction). The initial distribution of the 
fluorescently labeled lipid is close to the distribution expected from a sigmoidal model. 
Figure 47C shows the temporal evolution of the TopFluorPI(4,5)P2 gradient as a topology 
graph (see also the corresponding movie in the supplementary material). For this graph, 
a single raster across the channel perpendicular to the fluid flow was charted against time 
and color-coded to indicate the fluorescence intensity. The color map shows the time-
dependent equilibration of the gradient. It takes over 22 hrs for the gradient of 
TopFluorPI(4,5)P2 to equilibrate across the chamber. This is expected for a lipid diffusing 
via Brownian motion at about 2.7 - 2.8 μm2/s 8, 64, 70 in a 
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Figure 52. Temporal evolution of the PI(4,5)P2 gradient in the DOPC SLB. It takes over 22hrs for 
the TopFlourPI(4,5)P2 gradient to equilibrate across the 2 mm chamber. (A) Once an hour nine 
images were taken across the chamber and stitched together. Over time we see the brightest areas 
become dimmer and the darkest image parts becomes brighter indicating equilibration by diffusion (B) 
Integrated fluorescence intensities for each sub-image across the chamber at the beginning of the 
experiment. (C) Contour graph of the fluorescence intensity distribution as a function of time. The 
concentration ranges from 10nM to 60nM TopFlourPI(4,5)P2. 
TopFluorPI(4,5)P
2 
(nM)  
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chamber of 2 mm width. We found these measurements to be highly reproducible (n=5). 
For each set of parameters, i.e., TopFluorPI(4,5)P2 start concentration, flow speed, and 
SLB composition, the gradient is consistent and repeatable as measured by the 
equilibration time of the gradient. 
 The second option to obtain a PI(4,5)P2 gradient is to use vesicles with different 
compositions at the three inlet ports of the microfluidic device. To illustrate this approach, 
three unilamellar vesicle suspensions with the following compositions were made: 
10%PI(4,5)P2, 0.1%TopFlour PI(4,5)P2, 90%POPC; followed by 3%PI(4,5)P2, 
0.03%TopFlour PI(4,5)P2, 97%POPC; and 100% POPC (all percentages are mol%). 
These three initial vesicle compositions, when combined in the mixing tree, will result in 
nine ratios of the three compositions spanning across the outlets of the device. This is in 
contrast to the lipid monomer insertion,  where there are nine different concentrations of 
the monomeric lipid after mixing. In comparison to the monomeric lipid insertion method, 
where the degree of lipid insertion is unknown, this method has the advantage that the 
precise lipid composition in the SLB is known; in this case, the range of the gradient is 
10%PI(4,5)P2 – 0%PI(4,5)P2.  
Figure 53C shows quantitatively the temporal evolution of the lipid gradient, which 
is similar to the equilibration of the gradient obtained through lipid insertion (Figure 52C). 
One might be concerned that the deposition of lipid vesicles with different compositions 
may lead to patchiness at the submicrometer scale. However, the image does not reveal 
any patchiness (though such patches would be at the limit of the resolution of the 
microscope) and there is no other indication of such heterogeneities. We believe that 
mixing of the lipids between adjacent vesicles occurs during the formation of the SLBs. 
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Also, if such small patches existed, local diffusion would lead to mixing at a sub-minute 
timescale.     
Both methods, the lipid insertion and deposition of vesicles with different 
compositions, exhibit advantages and disadvantages regarding creating lipid gradients. 
The lipid insertion method creates very smooth gradients, while the deposition of vesicles 
with different lipid ratios leads to a less smooth gradient that has an initial appearance 
closer to a step function. Regarding the quality of the gradient, the lipid insertion method 
Figure 53. Gradient of PI(4,5)P
2
 obtained using vesicles with different PI(4,5)P
2
 concentrations. 
Vesicle suspensions with equal vesicle concentrations but different vesicle compositions were 
introduced into the three inlets of the microfluidic device. The vesicle compositions were 
10%PI(4,5)P2/0.1%TopFlourPI(4,5)P2/90%DOPC, 3%PI(4,5)P2/0.03%TopFlourPI(4,5)P2/97%DOPC, 
and 100%DOPC. The ratio of the unlabeled/labeled PI(4,5)P2 is kept constant for all vesicle 
compositions. It is assumed that distribution of the unlabeled PI(4,5)P2 mirrors the distribution of the 
labeled PI(4,5)P2 analog. (A) Image obtained by taking once an hour 9 images across the chamber and 
stitching them together. (B) Integrated fluorescence intensities for each sub-image across the chamber 
at the beginning of the experiment. (C) Contour graph of the fluorescence intensity distribution as a 
function of time.  
 
TopFluorPI(4,5)P
2 
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is therefore preferable. However, this method is limited by the type of the lipid that is being 
used and its concentration, since it requires the inserted lipid to be monomeric in solution. 
The major advantage of the vesicle deposition method is that one has complete freedom 
concerning the type of lipid gradient that is being created.  The experimental context will 
determine which method is the preferred one to answer a particular biophysical question.    
4.4 Effects of a Gradient of Ligand on Homogenous Bilayer 
To test whether a gradient of a solute interacting with a laterally homogeneous 
SLB can impart a gradient specific response in that SLB, we investigated the interaction 
of a Ca2+ gradient with SLBs composed of anionic lipids. The domain-forming effect of 
calcium upon interaction with anionic lipids like phosphatidylserine (PS) or PI(4,5)P2 
containing membranes is well established95. We hypothesized that the interaction of a 
Ca2+ gradient present in the bulk phase above mixed PC/PS or PC/PI(4,5)P2 SLBs leads 
to the formation of domains in a Ca2+ gradient-dependent manner.  
The interaction of PS with Ca2+ is well studied, and it has been hypothesized that 
Ca2+ interacts with the PS headgroup via two modes. (1) Ca2+ is interacting with the 
carboxylic acid group of the serine. (2) Ca2+ can also interact with the phosphate linker of 
the glycerol backbone 95-101. While it is unclear which type of interaction is the dominant 
one, either interaction can lead to a bridging of adjacent PS molecules, causing clustering 
of the lipid in mixed lipid bilayers. Visualization of PS clustering in an SLB with 
fluorescence microscopy is not trivial, and usually, high-resolution techniques like AFM 
are used to visualize these domains in fluid bilayers. To circumvent this problem, we used 
mixed POPS/POPC SLBs. POPS in the absence of Ca2+ has a gel/liquid-crystalline phase 
transition temperature of 14°C,102 i.e., POPC and POPS form a mixed fluid phase at room 
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temperature. In Langmuir film experiments, the addition of Ca2+ leads to condensation of 
PS monolayers 103, 104 and the addition of Ca2+ to a mixed POPC/POPS SLB is expected 
to give rise to domain formation in the leaflet distal to the glass support. We hypothesized 
that these PS domains would form in a Ca2+ gradient-dependent manner.  
 In figure 54, we show an SLB composed of 30% POPS, 0.1% TopFlourPS, and 
69.9%POPC as it interacts with a Ca2+ gradient. The Ca2+ concentrations of the solutions 
introduced into the inlet channels were 1mM, 2mM, and 3mM, respectively, and the 
experiment was carried out at room temperature. In contrast to the previous experiment, 
where we stopped the flow of the buffer solution during imaging, the Ca2+ gradient flow 
was maintained throughout the entire duration of the experiment. This was to avoid that 
the Ca2+ in the fluid phase equilibrates across the observation channel. Figure 54 is a 
montage of images that are obtained near the mixing channel outlets (see the 
corresponding movie in the supplementary material). The stitched image was obtained 
by combining individual images acquired across the channel using TIRF microscopy. This 
rastering was repeated once every 20 minutes over 3 hours (it takes 5min to obtain all 
images for the stitched image). POPS forms gel phase domains, as inferred from the 
jagged nature of the domain boundaries, upon interaction with the Ca2+ cations. The 
formation of these domains always starts in the area of the highest Ca2+ concentration, 
though the precise position within the high concentration region is difficult to predict. The 
mechanisms that lead to the seeding of these domains are unclear and exploring this 
aspect further is beyond the scope of this paper. After 30 minutes POPS/Ca2+ domains 
start to form and expand across the SLB as the Ca2+ continues to flow.  
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Figure 54. Montage of stitched TIRF images showing heterogeneous domain formation due to a 
Ca2+ gradient flowing over a homogenous SLB composed of 30%POPS/0.1%TopFlourPS/ 
69.9%POPC. Each stitched image covers a range of 2.0 X 2.5mm, and this raster was carried once an 
hour for 3 hours (5 minutes total time to obtain a full stitched image). This experiment was repeated five 
times, where the domain formation is always biased towards the high Ca2+ concentration, yet it is difficult 
to determine exactly where the domains will appear within this high Ca2+ concentration range. 
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 The domains form first in the regions with the higher Ca2+ concentration, and a gradient 
of domains across the channel remains as the experiment progresses. To further explore 
this phenomenon where a heterogeneous aqueous ligand can impart asymmetry on a 
homogenous SLB, we expanded these Ca2+ experiments to include lipid compositions of 
PI(4,5)P2 and PI(4,5)P2/Cholesterol. 
Figure 55 is a montage of one image area over time for a 5% PI(4,5)P2, 95% 
DOPC, 0.1% TopFlour PI(4,5)P2 SLB. After 20 min of Ca2+ exposure, we see the 
membrane punctuated with small areas of high fluorescence intensity. We believe that 
this is the result of TopFlour PI(4,5)P2 / PI(4,5)P2 clustering due to the bridging effect of 
Ca2+ (Ca2+ induced PI(4,5)P2 clustering has been previously reported by the Janmey 
group105, 106). Like previous experiments, we obtained images by rastering the objective 
across the observation chamber and acquired an image at nine locations across the 
membrane perpendicular to the fluid flow. This process was repeated once every five 
minutes for an hour. Each position was compiled as a movie (see supplementary material) 
and analyzed in ImageJ. Since the domains for the PI(4,5)P2/Ca2+ interaction are 
significantly smaller than that was found for the PS/Ca2+ interaction, we present the data 
in a slightly different way. We selected domains by setting a threshold for the intensity to 
create a binary image where the high-intensity regions were domains, and the low-
intensity regions were interpreted as background. Figure 56A shows the percent area 
covered by domains as a function of time and location within the chamber. Here we can 
see a dramatic increase in the percent area occupied by the 
PI(4,5)P2/TopFluorPI(4,5)P2/Ca2+ domains. The domain area increases from 0 to 3% of  
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Figure 56. Temporal evolution of PI(4,5)P2 domain formation upon interaction with a Ca2+ 
gradient. Images were obtained for a Ca2+ gradient flown over a homogenous SLB composed of 
5%PI(4,5)P2/0.1%TopFlourPI(4,5)P2/94.9%DOPC. The original data set was acquired by rastering the 
objective across the 2 mm observation chamber perpendicular to fluid flow, taking a total of nine images 
once every 5 minutes for an hour. The raw images were analyzed in ImageJ software (A) Number of 
PI(4,5)P2 %Area vs. time and location across the observation chamber (B) Domain number vs. time and 
location. To define a “domain”, for each image a threshold was set that distinguished the high-intensity 
areas from the background and then converted to a binary image. From this, each measurement 
compiled and the topology graphs constructed. Domains first appear at approximately 15 min after flow 
begins. By the end of the experiment, the domain number spans from about 100 to 400 domains. The 
number of domains as well as the area occupied by the domains is largest for the area with the highest 
Ca2+ concentration.  
 
 
Ca2+ Concentration (mM) Ca
2+ Concentration (mM) 
Figure 55. TIRF images for a single position showing domain formation due to the interaction of 
Ca2+ with a homogenous SLB composed of 5%PI(4,5)P2/0.1%TopFlourPI(4,5)P2/94.9%DOPC. The 
membrane was imaged once every 5min for an hour with a continuous flow of Ca2+ over the SLB. The 
high fluorescence regions appear after about 15-20 minutes. These high-intensity regions are thought 
to be due to the clustering of PI(4,5)P2 and it fluorophores due to Ca2+ interaction (for better image 
quality, please see the movie in the supplementary material). 
118 
 
the total image. The highest percent domain area correlates with the highest Ca2+ 
concentration. Domain formation in the regions with the lower Ca2+ concentrations occurs 
later than it is observed for, the higher Ca2+ concentration regions. Figure 56B shows the 
number of domains counted at each position (heatmap) as a function of time (x-axis) and 
position (y-axis). This topology image shows that for all time points the largest number of 
domains are found in the regions with the highest Ca2+ concentrations. Domain formation 
starts at around 20 minutes and reaches a plateau at about 30 minutes. While domain 
formation in the areas with the lower Ca2+ concentration starts at the same time, the 
number of domains in these regions is significantly less than what is found in the areas 
with higher Ca2+ concentrations. The effects of the Ca2+ on PI(4,5)P2 containing SLBs is 
evident by the spatiotemporal clustering of the PI(4,5)P2 fluorophore in response to the 
Ca2+ gradient. In addition to this, we noticed edge effects in this experiment. The increase 
domains at the edge of the microfluidic device may be caused by the disruption of the 
speed of the lamellar flow at the wall of the PDMS. This could lead to a longer interaction 
between the Ca2+ and the PI(4,5)P2 causing a more robust domain formation.  
It is well documented that cholesterol aids in the formation of PI(4,5)P2 domains in 
the absence and presence of Ca2+ 107-109. We would, therefore, expect that for the same 
experimental conditions as described above, the presence of cholesterol will cause 
domains to form faster and to grow to larger sizes. Figure 57 shows the development of 
PI(4,5)P2/cholesterol domains upon interaction with Ca2+ for one image area as a function 
of time, while the data in Figure 58 illustrate the development of the PI(4,5)P2/cholesterol 
domains upon interaction with a Ca2+ gradient. The Ca2+ has less impact on the  
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Figure 57. TIRF images for a single area showing domain formation due to the interaction of Ca2+ with 
a homogenous SLB composed of 5%PI(4,5)P2/0.1%TopFlourPI(4,5)P2/30%Cholesterol/64.9%DOPC. 
The SLB was imaged once every 5 min for an hour with a continuous flow of the Ca2+ gradient over the SLB. 
The high fluorescence regions appear after a period of 15min of Ca2+ flow. These high-intensity regions are 
thought to be due to the clustering of PI(4,5)P2/TopFlourPI(4,5)P2 due to the interaction with Ca2+. In 
comparison to the bilayer without cholesterol, there are more large domains at the start of the experiment. 
This is line with the hypothesis that cholesterol stabilizes these fluid PI(4,5)P2 domains. (for better image 
quality, please see the movie in the supplementary material). 
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Figure 58. Temporal evolution of PI(4,5)P2/cholesterol domain formation upon interaction with a Ca2+ 
gradient. Images were obtained for a Ca2+ gradient flown over a homogenous SLB composed of 
5%PI(4,5)P2/0.1%TopFlourPI(4,5)P2/30%Cholesterol/64.9%DOPC. The original data set was acquired by 
rastering the objective across the 2mm observation chamber perpendicular to fluid flow, taking a total of nine 
images once every 5 minutes for an hour. The raw images were analyzed in ImageJ software (A) Number of 
PI(4,5)P2/cholesterol domains vs. time and location across the observation chamber. (B) Percent domain area 
relative to the total field of view vs. time and location. To define a “domain”, for each image a threshold was set 
that distinguished the high-intensity areas from the background and then converted to a binary image. From 
this, each measurement compiled and the topology graphs constructed. Domains first appear at approximately 
15 min after flow begins. By the end of the experiment, the domain number spans from about 100 to 400 
domains. The number of domains as well as the area occupied by the domains is largest for the area with the 
highest Ca2+ concentration. 
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cholesterol/PI(4,5)P2/DOPC SLB morphology (Figure 58) than that observed in the 
absence of cholesterol (Figure 55). For the cholesterol-containing SLB, PI(4,5)P2 
enriched domains can be seen even in the absence of Ca2+ (before the addition of Ca2+). 
In particular, for the regions with lower Ca2+ concentrations (1 mM and 2 mM Ca2+), where 
for the cholesterol-free SLB only moderate domain formation occurred, an increased 
number of domains are found. From a kinetic point of view, the plateau where no 
additional domain formation is observed is reached faster (about 25 minutes after the 
Ca2+ was introduced in the chamber, see Figure 58). Furthermore, there is less domain 
size disparity; without the cholesterol, the domain sizes ranged from 5 to 15 pixels, while 
in the presence of cholesterol the size range is 10 to 13 pixels. This is likely due to the 
domain stabilizing effects of cholesterol, which leads to larger domain size. The percent 
domain area plot shows for the SLB with cholesterol a shallower gradient as compared 
with PI(4,5)P2 only. These results are in agreement with the earlier formulated hypothesis 
that cholesterol stabilizes PI(4,5)P2 domains, i.e., while an additional PI(4,5)P2 domain 
forming effect is observed in the presence of Ca2+, the impact of the Ca2+ on domain 
formation is less profound than in the absence of cholesterol108, 109. The edge effects are 
also less pronounced in this experiment as compared to the former.  
  These three experiments, PI(4,5)P2, PI(4,5)P2/Cholesterol, and POPS (in a DOPC 
SLB) show domain formation as an effect of Ca2+ exposure. As expected, the extent of 
domain formation is highly dependent on the Ca2+ concentration as evidenced by the Ca2+ 
gradient dependent kinetics of anionic lipid domain formation. These experiments 
underscore the versatility of the microfluidic device because not only can we successfully 
produce lipid bilayers exhibiting a lipid gradient but it is also possible to expose a 
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homogenous bilayer to a gradient of a solute in the aqueous phase, which triggers a 
gradient specific response.  
 In addition to what has so far been discussed, we have discovered an unexpected 
but highly welcomed side effect of using the microfluidic device. SLBs that contain highly 
negatively charged lipids are usually challenging to form. We have found with our method 
that the microfluidic device helps with the SLB formation (fewer defects in comparison to 
more traditional methods110). We attribute this to the shear forces the vesicles experience 
as they are entering the observation chamber, which apparently leads to a better settling 
of the lipid bilayer onto the glass support. While we have not tested this exhaustively, we 
expect that the use of the microfluidic device will expand the scope concerning lipid 
composition, allowing us to conduct experiments with more complicated, physiologically 
relevant lipid compositions. 
Despite the robustness of the experiments described above, we realize that the 
size of the observation channel is too large to accomplish one of our goals, which is to 
investigate lipid gradients at physiologically relevant length scales. The comparatively 
large size of the observation channel presents a two-fold problem. (1) From a logistical 
point of view, the experiments take far too long, over 24hrs, for the gradient to come to 
equilibrium. This not only limits throughput, but it also requires control of all experimental 
parameters (e.g., temperature) over quite long time periods. (2) Physiologically relevant 
length scales are in the range of tens of microns, while our observation chamber has a 
width of 2 mm. With this in mind, we fabricated a different microfluidic platform with a 
design based on a device developed by the Whitesides group91. 
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Figure 59 shows the design and dimensions of the microfluidic device with a 
tapered design. There are several choices of observation widths ranging from 900 μm 
down to 50 μm. The large size would be used for experiments where one wants to look 
at several frames of similar membrane composition, providing replicates of an experiment 
from a single microfluidic setup. The 100-micron and 50-micron size chambers are useful 
for studying effects in the SLB at length scales that are similar to large cells. Also at 
100μm, the entire channel can fit in the field of view of the microscope, making it 
unnecessary to stitch images together to acquire gradient information.  
To test whether the gradient in the fluid phase is maintained throughout the entire 
device, we experimented with a fluorescein gradient (figure 55, a pure glass substrate 
with no SLB). The experiment was carried out at several different flow rates to illustrate 
how the steepness and functional form of the gradient can be manipulated. For the 
highest flow rates, the gradient assumes the form of a step function, while at slower flow 
rates the gradient is smooth. Most importantly, there is a gradient of fluorescein  
Figure 59. Microfluidic platform design with tapered features which allows to choose several 
different widths to explore gradients in artificial membranes. The smallest widths are at the 
maximal end of large cell diameters allowing us to conduct more physiologically relevant experiments. 
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Figure 60. TIRF images of a fluorescein gradient flowing through the tapered microfluidic device at 
different flow rates. Despite the tapered design, the gradient in the aqueous phase is maintained. These 
experiments highlight the effect of the flow rate on the steepness of the gradient. For the slowest flow rate the 
gradient is smooth and integrated, while for high flow rates the fluorescence intensity has the form of a step 
function. 
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throughout the entire tapered design, even in 
the last compartment with the smallest 
dimension (Figure 60 and Figure 61). As the 
last step, we tested the tapered design by 
performing the TopFluor® PI(4,5)P2 SLB 
insertion experiment in the same way as 
described above for the conventional 
microfluidic device. Figure 62 shows two 
images from the beginning and end of a movie 
showing TopFluor®PI(4,5)P2 inserting as a 
gradient (see supplementary material for the 
movie). The gradient comes to equilibrium 
corresponding to the size of the channel, i.e., 
the smallest channel equilibrates quickest (~ 
10 min), while for the largest channel it takes 
the longest (~10 hrs). With this design, we now 
have access to PI(4,5)P2 gradients on 
membranes with physiological dimensions 
and realistically testable time spans (Figure 62 and 63). 
4.5 Conclusions and Outlook with the microfluidic platform 
Cells have micron scale control over their plasma membrane morphology as seen 
by the formation of lipid and protein gradients during processes like chemotaxis or 
cytokinesis. We have developed a device that enables the fabrication of solid-supported  
 
Figure 61. Image of the fluorescein 
gradient in the two narrowest chambers. 
The gradient is well maintained throughout 
the entire microfluidic device. 
50μM
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Figure 62. Shows the first TIRF stitch image of TopFlourPI(4,5)P2 inserted as a gradient in SLB 
composed of DOPC and the final image after the PI(4,5)P2 gradient comes to equilibrium. 
Figure 63. Is the zoomed in area montage of the TopFlourPI(4,5)P2 experiments showing the 
gradient in the narrow chambers. 
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lipid bilayers that exhibit a lateral gradient concerning their lipid composition. Also, we 
have shown that we can elicit a gradient specific response in a homogenous lipid bilayer 
when this bilayer is in contact with a fluid that exhibits a gradient of one or more of its 
components. 
We have successfully generated a PI(4,5)P2 gradient which is testable and robust. 
We can make the SLB in situ on the TIRF microscope by either floating monomeric lipid 
molecules over the preformed SLB or by laying down vesicles that exhibit differences in 
lipid composition. Ca2+ gradient-dependent domain formation on PI(4,5)P2, 
PI(4,5)P2/Cholestrol, and PS-containing membranes illustrates that we can elicit a 
gradient specific response when a homogeneous SLB is exposed to an appropriate 
gradient in the fluid phase. This opens up the opportunity to use a gradient of protein, 
e.g., a lipid-modifying enzyme, in the fluid phase and to study the spatiotemporal 
response in the lipid bilayer. With the most recent iteration of our platform, we can 
generate a gradient on length scales typical for large cells.  
In the future, we plan to use this platform to quantitatively ascertain the stochastic 
balance between the phosphatase PTEN and the kinase PI3K as these proteins interact 
with a PI(4,5)P2 containing bilayer. We hope to fill gaps in the current mechanistic 
understanding of motility and cancer metastasis work. Such dynamic protein competition 
on laterally non-homogeneous SLBs, as we have developed in this study, would be a 
highly interesting target to investigate. 
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5.0 Future Directions 
5.1 Kinetics Experiments 
 The next place to take this work is the further development of the global fit model. 
Experiments done with lipid mixtures of PI/cholesterol and PI(4,5)P2/cholesterol would 
further establish the effects of lipid domains on PTEN membrane binding. These domains, 
in contrast to PI(4,5)P2/PI, cluster the phosphoinositide without the addition of charge. 
This allows us to explore the effects of the spatial density of PI(4,5)P2 without adjusting 
the overall potential of the lipid vesicle. A question one would ask is which lipid 
composition, 5%PI(4,5)P2 or 5%PI(4,5)P2/cholesterol, has the faster rate constant. If the 
trends continue with what we have observed, it would be expected that 
5%PI(4,5)P2/cholesterol would have a slower kon but also have a more stable interaction 
(slower koff). In this case, what is the determining factor, is the koff so slow that it effects 
the Kd resulting in a net increase of PTENs on the lipid vesicle? Or, is the protein crowding 
competitive enough that the increased stability has little effect, i.e there are too few 
binding sites to be useful.  
 Exploration with the stopped-flow of different domain constructs of PTEN would 
expand the kinetic story. These data could also be used to validate the single-molecule 
results. With the C2 domain a different FRET pair would have to be constructed since 
there is no tryptophan occurring in the sequence. Since the ybbR tag is already present, 
this should be a simpler route than re-cloning the protein with tryptophan. To continue to 
parse out the effects of specific binding, mutations studies of PTEN at sites such as H93 
should be undertaken. Data with these disease constructs would continue to develop the 
understanding of the diseased phenotypes and new therapeutic pathways would be 
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revealed.  In addition to this experiments with wtPTEN and mixed PI(5)P/ PI(4)P could 
also be informative. It would be interesting to see if these phosphoinositides would induce 
a second step or not in the kinetic data. In addition, would there be a change in the 
diffusion coefficients, indicating a decreased protein-lipid interaction, or would the 
population distribution shift? 
 This thesis is as much about PTEN and lipids as it is about how to describe proteins 
binding to these dynamic surfaces. We argue that a protein binding to a negatively 
charged membrane can use both electrostatics and a bi-molecular approach. For every 
example of a protein interacting with a membrane due to pure electrostatics (MARCKS) 
there is one where the chemistry matters (PH domains). Conceptually it is easy to say, 
the protein feels the electrostatic field which drives it to the membrane through the 
electrostatic double layer to have an interaction with the lipid membrane. At some point 
during this process peptides seem to behave as if interacting with individual lipids rather 
than “just” a negatively charged surface. A barrier to determining the true kon value is how 
do you count the lipids to appropriately describe the bimolecular model? Conversely, one 
could account for the complex stability by reporting the koff values, which are concentration 
independent.  A simple investigation that needs to be explored is to find the experimental 
dissociation constant. We have available to us the reagents and the equipment. By finding 
these values they can be directly inserted in the KinTeK global fit program while allowing 
the others values to float. This would allow for the exploration of other models with multiple 
steps (Figure 48). In addition, these values can be used to validate the single molecule 
dwell time results above.  
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  The more sophisticated solution is an investigation of single molecule kinetics. It 
would be very interesting if single molecule FRET could be designed to directly probe the 
PI(4,5)P2 and PTEN interaction. If it is possible to get a high enough signal with TIRF you 
could quantify the amount of free donor vs. FRET. Since all of the PTEN that we can see 
is bound to the membrane, we would observe the “electrostatic” PTEN vs. “PI(4,5)P2-
bound PTEN. Both the life-times of each species would be informing with how proteins 
deal with complex lipid surfaces. How would the relationship change with lipid domain 
containing supported lipid bilayers?  
 In addition to this, the cumulative dwell times can also be fit in the global fit 
software. In combination with the ensemble experiments we could define a detailed, 
complex protein-membrane interaction. Ultimately, if these experiments are expanded to 
other phosphoinositide metabolizing/interacting proteins would we uncover a generalized 
mechanism. Do other phosphoinositide binding proteins use this coincidence detection 
and multimodal membrane interactions as a means to scan biological surfaces efficiently? 
How does this change in disease and is there a way to rescue the diseased membrane 
surface?  
5.2 Microfluidics   
 The next step in the microfluidic device project is to explore the effects of proteins 
on these membranes. The first thing I would do is acquire a labeled PH domain specific 
for PI(3,4,5)P3 and see if we could see a gradient of these lipid through the PH domain 
binding. Once that is established I would flow PTEN as a homogenous solution over a 
lateral gradient of PI(3,4,5)P3 and follow the catabolism of the phosphoinositide as a 
function of the loss of the PH domain. It would be interesting to follow the turnover with 
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different membrane compositions and explore the rate of the lateral gradient decay. After 
this system was well established I would explore this with PI3K and then have a 
competition experiment between the kinase and the phosphatase. It would also be 
interesting to design an even narrower microfluidic chamber (10-5 microns) and see if 
stochastic effects begin to dominate the averaging behavior. Since those sizes are 
cellular dimensions, it may lead to unique insights on how these enzymes behave on a 
complex membrane surface.  
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Appendix 
Procedure for the BioRade FPLC: 
(1) HPLC water 20 mL at 2mL/min. 
(2) Stripping Buffer (20 mM HEPES pH 7.5, 500mM NaCl, 50mM EDTA).10mL at 
1mL/min. 
(3) HPLC water 20mL at 2mL/min. 
(4) NiSO4 (100mM) 3mL 1mL/min. 
(5) HPLC water 20mL at 2mL/min. 
(6) Equilibration Buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 5mM Imidazole,10 
mM B-ME) 20mL at 2mL/min. 
(7) Lysis Supernatant 1mL/min until full volume is gone. 
(8) Equilibration Buffer 20mL at 2mL/min. 
(9) Elution Buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 500mM Imidazole,10 mM 
B-ME) 10mL at 1mL/min. 
(Collect the elution which corresponds to the 280nm peak.) 
(10) HPLC water 20mL at 2mL/min. 
(11) 20% Ethanol 20mL at 2mL/min and store column at 4 °C. 
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The protein is then dialyzed overnight in 1L of (150 mM NaCl 20mM HEPES pH 7.5, 10 
mM B-ME). Then the solution is passed over a Chitin column and an HiTrap Q HP anion 
exchange column. 
The procedure for the chitin column with 1 mL of slurry wash with: 
(1) HPLC water 30 mL. 
(2) Dialysis Buffer 30 mL. 
(3) Cap the bottom of the column, add protein solution, cap top of the column and 
mix for 30min. 
(4) Collect flow through from Chitin column. 
(5) Add three mL of dialysis buffer and collect with protein sample. 
(6) HPLC water 30 mL. 
(7) 0.3M NaOH 10 mL. Cap bottom and top and mix overnight. 
(8) HPLC water 30 mL. 
(9) 20% ethanol solution 30 mL and store at 4 °C. 
The final purification step occurs with the 1 mL HiTrap Q HP column (GE) on the FPLC. 
The procedure is as follows: 
(1) HPLC water 20 mL at 2mL/min. 
(2) High Salt (1 M NaCl, 20 mM HEPEs pH 7.5, 10 mM B-ME) 20 mL at 2mL/min. 
(3) Low Salt (150 mM NaCl, 20 mM HEPEs pH 7.5, 10 mM B-ME) 20 mL at 2mL/min. 
(4) Pass flow through from Chitin column (protein) at 0.5mL/min. 
(5) Low Salt 20 mL at 1mL/min. 
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(6) Gradient Low Salt to High Salt 60mL at 1mL/min. PTEN elutes 17mS-27mS. 
Collect 12X 1mL fractions and run a SDS PAGE gel to determine the purest, 
highest concentration fractions. 
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Stopped-flow 
98% PS stopped-flow raw data. Top graph is the analytical graph used to 
determine on and off rates of PTEN binding to mixed vesicles. Bottom graph is 
an example of the raw data used in the graph above and the global fit. 
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98% PI stopped-flow raw data. Top graph is the analytical graph used to 
determine on and off rates of PTEN binding to mixed vesicles. Bottom graph is 
an example of the raw data used in the graph above and the global fit. 
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30% PS stopped-flow raw data. Top graph is the analytical graph used to 
determine on and off rates of PTEN binding to mixed vesicles. Bottom graph is 
an example of the raw data used in the graph above and the global fit. 
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  30% PI stopped-flow raw data. Top graph is the analytical graph used to 
determine on and off rates of PTEN binding to mixed vesicles. Bottom graph is 
an example of the raw data used in the graph above and the global fit. 
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5%PI(4,5)P2 stopped-flow raw data. Top graph is the analytical graph used to 
determine on and off rates of PTEN binding to mixed vesicles. Bottom graph is 
an example of the raw data used in the graph above and the global fit. 
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1%PI(4,5)P2 10%PS stopped-flow raw data. Top graph is the analytical graph 
used to determine on and off rates of PTEN binding to mixed vesicles. Bottom 
graph is an example of the raw data used in the graph above and the global fit. 
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1%PI(4,5)P2 10%PI stopped-flow raw data. Top graph is the analytical graph 
used to determine on and off rates of PTEN binding to mixed vesicles. Bottom 
graph is an example of the raw data used in the graph above and the global fit. 
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5%PI(4,5)P2 30%PS stopped-flow raw data. Top graph is the analytical graph 
used to determine on and off rates of PTEN binding to mixed vesicles. Bottom 
graph is an example of the raw data used in the graph above and the global fit. 
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5%PI(4,5)P2 30%PS stopped-flow raw data. Top graph is the analytical graph 
used to determine on and off rates of PTEN binding to mixed vesicles. Bottom 
graph is an example of the raw data used in the graph above and the global fit. 
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Single-molecule velocity graphs of lipid diffusion. The data is at least 2N for the 
matching exposure times. From these data the diffusion coefficient is 
determined from the line. 
Single-molecule velocity graphs of wtPTEN on 30%PS 3%PI(4,5)P2 SLB. The 
data is at least 2N for the matching exposure times. From these data the 
diffusion coefficient is determined from the line. 
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Single-molecule velocity graphs of wtPTEN on 3%PI(4,5)P2 SLB. The data is 
at least 2N for the matching exposure times. From these data the diffusion 
coefficient is determined from the line. 
Single-molecule velocity graphs of wtPTEN on 30% PS SLB. The data is at 
least 2N for the matching exposure times. From these data the diffusion 
coefficient is determined from the line. 
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at least 2N for the matching exposure times. From these data the diffusion 
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Single-molecule velocity graphs of delPTEN on 30% PS SLB. The data is at 
least 2N for the matching exposure times. From these data the diffusion 
coefficient is determined from the line. 
Single-molecule velocity graphs of C2 on 30% PS 3%PI(4,5)P2 SLB. The data 
is at least 2N for the matching exposure times. From these data the diffusion 
coefficient is determined from the line. 
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